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1.1 General aspects of a malaria infection 
Malaria is a predominant public health problem in tropical areas with rainfall throug-
hout the year. Human disease is caused by parasites in red blood cells that belong to four 
species of Plasmodium: Plasmodium vivax, Plasmodium ovale, Plasmodium malariae and 
Plasmodium falciparum. Malaria tropica caused by P.falciparum is a main cause of severe 
illness and death. In recent years the problem has been aggravated by the develop-ment of 
resistance against the drugs that were in common use for the treatment of this infectious 
disease. Worldwide it is estimated that there are about 300-500 million clinical cases of 
malaria of which about 90% occur in Africa alone and that there are between 1 .5 -3 
million deaths per year with 800.000 deaths in African children 164|. 
The malaria parasites are transmitted from man to man by several species of Anopheli-
ne mosquitoes. The wide distribution of malaria is attributable to the adaptability and 
breeding potential of the Anopheles mosquito. The greater part of the population is infec-
ted with the parasite in regions where the conditions favour transmission throughout the 
year; this situation is indicated as hyperendemic malaria. Under those circumstances the 
indigenous people are continuously exposed to infectious mosquito bites. The clinically 
severe malaria infections occur in people which are insufficiently immune against the 
parasites. It is evident that protective immunity can be developed through natural exposure 
to the malaria parasites. In areas of intense transmission, the bulk of morbidity and 
mortality as a result of malaria infection occurs in infants, children under five years of age 
and pregnant women. The children still have to establish their own active species and 
strain specific antimalarial immunity and women experience during pregnancy a physiolo-
gic period of immune depression. The severity and frequency of malaria attacks gradually 
decline with age until only relatively mild and sporadic episodes occur from adolescence 
onwards. Even then, the acquired immunity is less than solid, and occasional episodes of 
parasitemia and disease persist throughout life. 
It is a common view that malaria immunity is build on the individual experience with 
various types of locally available malaria parasites species and their strains4 [18]. Those 
who survive the first years of repeated infections develop clinical immunity and premuniti-
on [53]. According to this concept a status of a persisting low grade parasitic infection of 
the blood provides a gradually acquired immune protection against superinfection with the 
locally present parasite species and strains. Radical treatment with antimalarial drugs 
&
 The concept "parasite strain is still ill-defined and describes within a species a geographically 
restricted subpopulation of parasites which share one or more characteristics ot interest, e g closely 
related antigenicity. 
10 
Introduction 
results in the loss of parasites and if premune people are no longer exposed to reinfection 
effective premunition is lost within a period of several months In persons who have 
acquired through regular infections parasitemia may exist without malaria illness In 
premune people exposed to regular infections the chronic parasitemia is not accompanied 
by major acute clinical symptoms. These people contribute to maintaining the infectious 
malaria reservoir in the local mosquito population in this way Therefore migrants from 
geographically different regions where other malaria parasite strains are present as well as 
non-immune visitors remain at risk for acquisition of clinical infections. 
1.2 Biology of the sexual stage of Plasmodium falciparum 
The complex life cycle of the malaria parasite, comprising several stages which are 
morphologically, biochemically and antigenically distinct is schematically drawn in Figure 
1 Natural malaria infection develops after injection of sporozoites (A) into the host's 
bloodstream when a female Anopheles mosquito takes a bloodmeal. The sporozoites 
rapidly leave the circulation and invade host liver cells and become exoerythocitic schi-
zonts (B) leading to the development of thousands of merozoites On release from the 
disintegrating liver cells into the bloodstream, the merozoites (C) invade erythrocytes, 
mature through an erythrocytic trophozoite (D) and finally erythrocytic schizonts divide 
into 8 to 32 new merozoites (E) which are released as daughter cells when the erythrocy­
te bursts These merozoites invade other erythrocytes, thereby continuing the erythrocytic 
cycle of parasite multiplication, which is the only stage of the infection that is accompa­
nied by clinical manifestations of the disease and which takes 48 hours for completion (72 
hours in Ρ malanae) During the process of erythrocytic schizogony some parasitized 
erythrocytes are induced to differentiate from asexual into sexual stages of the parasite 
(F), the so called male and female gametocytes [28,6]. The mechanism of this induction is 
as yet unknown [47,12]. The immature gametocytes of Ρ falciparum mature while adhe­
rent to the endothelial cells of small vessels The development to morphological and 
functional maturity [47,57,48,12] requires at least 7 days and they become microscopically 
detectable in bloodsmears some 10 days after the asexual parasitemia became patent 
Gametocytes are apathogenic and become functionally active only when they are ingested 
by an Anopheles mosquito after taking an infected bloodmeal The mature and functional 
gametocytes in the mosquito midgut are stimulated to transform into extracellular male 
and female gametes (G) under influence of changes in temperature, pH and C0 2 [58,56,8-
,12] The microgametocyte (male form) forms eight highly motile microgametes [29] and 
the macrogametocyte increases the cell volume and 'rounds up' [55,12] Fertilization of 
the macrogametes ensues, and is complete within 10 - 30 minutes after ingestion of a 
11 
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Figure 1 Life cycle of the human malaria parasite Plasmodium falciparum 
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blood meal [58,55,12]. The fertilised zygotes transform into retort cells and further into 
motile ookinetes (I) that makes contact to the cells lining the stomach wall. 
The ookinetes penetrate through or between the epithelial cells of the stomach wall and 
finally rest on inner side of the lamina basalis of the epithelial cells on the outside surface 
of the stomach wall where they develop into oocysts (J) [36,37]. Within the oocyst 
thousands of sporozoites are formed (K) which, upon rupture of the oocyst, migrate via 
the haemocoel to the salivary glands. 
1.3 Immunity to the sexual stages 
Many patients show gametocytes for the first time about three weeks after a sporozoite 
induced infection, or two to four days after the first day of a recrudescence. Shute and 
Maryon [54] and Wilson [66] have shown that in children <5 years of a hyperendemic 
region, gametocytes are more abundant and the prevalence of carriers higher than in any 
other age group. In countries with one transmission season only, gametocytes are more 
abundant and seen relatively more frequently in adolescents and adults in comparison with 
hyperendemic regions. Thus gametocytaemias are more prevalent before clinical immunity 
is acquired. In addition, non-immune adults who have entered the area and become 
infected can become good gametocyte producers and good transmitters. 
Antibodies to gametocytes of Ρ .falciparum were first reported by Voller and Bray [63] 
using immunofluorescence. Antibodies directed against surface antigens of sexual stage 
parasites can be induced in the vertebrate host by immunization with gametocytes, game­
tes or purified antigens [7,25,9,40,10,27,4]. These antibodies propably do not have access 
to gametocytes in the bloodstream, where they are protected by the red blood cell mem­
brane, but they can interact with the parasite cell surface of gametes. Four different 
groups of monoclonal antibodies (mAbs) were shown to be effective in reducing transmis­
sion: (1) antibodies against gamete surface antigens which propably block parasite fertili­
zation [7,25,9,39,45]; (2) anti-gamete antibodies inducing complement-dependent lysis of 
gametes and fertilized zygotes [51,45,38]; (3) antibodies against ookinete surface antigens 
which inhibit post-fertilization growth and development [60,38,67] and (4) opsonizing 
antibodies showing white blood cell dependent transmission-reduction [35]. Antibodies are 
considered the most important immune mediators that reduce transmission but evidence 
has been presented that other mechanisms including phagocytic leucocytes [56], cellular 
immunity [26], cytokines and reactive nitrogen intermediates [44,46] may affect transmis­
sion. Transmission-blocking (ТВ) immunity, that is directed against the sexual stages of 
parasitic development, prevents the fertilization process or the further development of 
oocysts and no sporozoites are formed, thereby preventing spreading of the parasite [9, 
13 
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27]. ТВ-immunity is observed in the analysis of serum of people living permanently or 
periodically in endemic areas and who where infected with the parasite [45,38,231 
1.4 Target antigens of Transmission-Blocking (ТВ) antibodies 
As targets for antibodies, a number of Ρ falciparum gametocyte and gamete antigens 
have been identified by immunoprecipitation, metabolic labelling and 'pulse and chase' 
experiments [42,60,62] Antigens present in blood stage gametocytes and retained in 
mosquito midgut on the surface of freshly emerged gametes include Pfs230, Pfs48/45 and 
Pfs40/10 (Table I). These are pre-fertihsation antigens and it is likely that natural immuni­
ty against such antigens is boosted by a malaria infection. During the transformation of a 
zygote into an ookinete a change in the composition of the parasite surface proteins 
occurs, ι e Pfs230 and Pfs48/45 are shed from the surface and a newly synthesized 25-
kDa (Pfs25) protein appears on developing zygotes, retort cells and ookinetes Up to now 
these proteins have been preferentially studied though other proteins were also found on 
the surface, e g Pfs40/10 and Pfs28 
TABLE I Sexual stage proteins of Ρ falciparum of which genes are expressed 
Protein 
Ptg377 
Pfs230 
Pfs48/45 
Pfs40/10 
Pfs28 
Pfg27/25 
Pfs25 
Pig 16 
Pf 11 1 
Chitinase 
Location of protein 
gametocyte dense bodies 
gametocyte and gamete surface 
gametocyte and gamete surface 
gamete surface 
gamete and ookinete surface 
gametocyte internal 
gamete and ookinete surface 
gametocyte pasitophore vacuole mem-
cytoplasm of gametocyte infected RBC 
Induction of ТВ 
no? 
yes 
yes 
no' 
yes 
yes9 
yes 
no 
yes' 
yes 
References 
[3] 
[51.60,49,1-
[51.60 16,1] 
H.50I 
1191 
168,15,2] 
|60,1,31| 
[5.43] 
[20,52| 
[17] 
Pfs25 and the newly identified parasite-specific chumase are post-fertilisation antigens 
expressed exclusively in the mosquito midgut The biological function of the described 
proteins is still not known It is assumed that antibodies against Pfs230 and Pfs48/45 
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interfere in the process of fertilization, since antibodies directed against these antigens 
block further development of the parasite [51,60]. It has been suggested that antibodies 
against Pfs25 interacts with a ligand of the ookinete for a receptor on the mosquito midgut 
wall, preventing penetration of the ookinete [60]. 
Epitopes of the Pfs230 surface protein. 
In Ρ falciparum, mAbs directed against the 230-kDa protein block the further develop­
ment of the gamete or zygote only in the presence of complement [49]. Only in P.galhna-
ceum a reduced gametocyte infectivity was shown by a synergistic effect of two distinct 
mAbs directed against the Pfs230 analogous in the absence of complement [32]. Two 
epitopes on Pfs230 were identified as targets of TB-mAbs. One was shown to be univer­
sally conserved within 45 isolates; the other was demonstrable again in all isolates, though 
3 of the isolates had small populations of gametocytes that did not react [21] 
Epitopes of the Pfs48/45 surface protein. 
A number of anti-Pfs48/45 mAbs are able to block transmission of the parasites to the 
mosquito vector [51,60,16,59] The immunological reactivity of the epitopes of Pfs48/45 
was investigated in more detail in a two-site radio-immuno assay. Based on competition, 5 
distinct antibody epitopes have been identified, however none of them being particularly 
associated with the capacity to induce ТВ [11,61,13,16,59]. These epitopes are monova-
lently expressed on the proteins Epitope II is subdivided into epitopes a, b and с of which 
a and с represent the genetic variants [16] In addition, Foo et al. [21] found in a sene of 
33 Ρ falciparum isolates from Malaysia thai variation exists in epitope Ila and lie, while 
epitope I, lib, III and IV are markedly conserved. Using the PCR technique nucleotide 
and amino acid sequence differences were observed between the Pfs48/45 genes of 8 
different strains of Ρ falciparum by Koeken et al. [33]. The amino acid residue at position 
254 in Pfs48/45 determines whether epitope Ila or He is expressed. 
Structure of Pfs25 
Pfs25 is a cysteic-nch (> 10% of the residues) glyco-protein on the surface of game­
tes, zygotes and ookinetes Two distinct antibody binding sites have been identified, one 
of which is target for TB-immumty Both epitopes are conformational and dependent on 
the tertiary structure of the protein and on the presence of linked fatty acids, but indepen­
dent of carbohydrate groups [60,22] Foo et al. [21] showed that epitope I, which is target 
of TB-mAbs showed some variability amongst 45 Malaysian isolates, while epitope II was 
conserved throughout The gene encoding Pfs25 has been isolated [31] and is characteri­
zed by the presence of four tandem epidermal growth factor (EGF)-like domains Only 
minimal variations in antigenic composition were found among different isolates of P.fal-
ciparum [30] and this would be consistent with the view that Pfs25 is not subjected to 
15 
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immune pressure in the human host and does not show polymorphism 
Other membrane proteins 
The role in ТВ-immunity of several other proteins (e g Pfg377, Pfs40/10, Pfg27/25, 
Pfsl6, Pf 11 1 and chumase) of the sexual stages of Ρ falciparum is not clear (see Table 
1) and only few data about these proteins are available The mechanisms of action of the 
ТВ-antibodies which react with intracellular proteins of sexual stages such as Pfg27/25 
and Pf 11 1 are not understood It has been found that a mAb against Pfg27/25 cross 
reacts with an epitope shared between Pfs230 and Pfs48/45 [68] and this may be the ТВ 
target of this mAb 
1.5 Outline of this thesLs 
The gametocytes are non pathogenic in the human host and their only goal is to infect 
mosquitoes, thus transmitting the parasites Though Ρ falciparum 230 kDa and 48/45 kDa 
proteins are expressed predominantly on the gamete surface, their synthesis begins at an 
early stage in gametocyte development This expiâmes the presence of antibodies to these 
target antigens in sera from infected individuals [41,24,14] Sexual stages can induce 
immune responses that may affect the outcome of the infection in the mosquito, e g , 
antibodies against the sexual stage specific Pfs230 and Pfs48/45 MAbs against these 
proteins do have TB-activity 
The direct laboratory test for the analysis of Ρ falciparum ТВ-immunity is the in vitro 
feeder assay, indicating as the bioassay based on development of oocysts in mosquitoes 
after membrane feeding of gametocytes in the presence of the serum control and test 
samples [60] It is a labounous, time-consuming and costly assay whereby only a restnc 
ted number of sera can be tested Therefore an alternative testmethodology is needed for 
the assessment of ТВ-immunity in the field and of future TB vaccins with regard to their 
impact on the infectious gametocyte reservoir in the local population The objectives of 
the studies described in this thesis were as follows 
1) the development of serological tests to study the presence of antibodies against Pfs230 
and/or Pfs48/45 in sera from naturally infected individuals 
2) to study the association between the presence of these antibodies and the capacity of 
sera to block Ρ falciparum transmission. 
MAbs, recognizing Pfs230 were used in specific competition ELISAs to study the associa­
tion between the presence of those antibodies and ТВ-activity of human serum samples 
(chapter II) To determine whether anti-Pfs230 mAbs mediated transmission-blockade is 
isotype and epitope dependent, a number of isotype switch variants were prepared and 
selected for differences in their capacity to fix complement (chapter III) Anti-Pts230 
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mAbs and anti-Pfs48/45 mAbs were used in competition ELISAs for the detection of 
natural antibodies in sera from gametocyte carriers and to compare these results with TB-
activity of these sera in the bio-assay (chapter IV). In chapter V and VI the association 
was studied between ТВ-activity and competit ion-ELISA titers against different epitopes of 
Pfs48/45 among different isolates of Ρ .falciparum. Antibody activity in competition-
ELISAs and the activity of the serum in the TB-bioassay was longitudinally studied in 
blood samples collected from adult patients with a P.falciparum malaria on admission and 
at several time points after malaria treatment (chapter VII). A summary and general 
discussion is given in chapter VIII. 
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ABSTRACT 
The activity was analysed of monoclonal antibodies (mAbs) that specifically recogni­
ze the P.falciparum sexual stage specific protein Pfs230 All mAbs reacted with the 
surface of extracellular sexual forms of the parasite in a "suspension immunofluorescence 
antibody reaction (SIFA)" and precipitated the Pfs230 protein from an NP-40 extract of 
surface radio-iodinated macrogametes/zygotes. Only mAb that bound complement blocked 
transmission whereas mAb that did not bind complement but competed with the comple­
ment binding mAb for binding to the same epitope did not block transmission. These 
mAbs were used to develop Pfs230 specific competition ELISAs to analyse epitope 
diversity and to analyze the binding characteristics of anti-Pfs230 antibodies in human 
serum. Transmission-blocking (TB) antibodies in test/field sera competed in the competiti­
on ELISA for binding with epitope specific, labelled mAbs against Pfs230 At least 5 
different epitope regions could be defined with the competition ELISAs 
All 46 sera from gametocyte carriers immunoprecipitated the Pfs230 molecule while 
19 of these sera blocked transmission in the bioassay. Five of the transmission-blocking 
and one of the non-blocking sera competed with monoclonal antibodies A method compa­
rison analysis was used to determine agreement between reactions in a competitive ELISA 
and the ТВ-activity examined in the bioassay. The index of agreement К between outcomes 
of the bioassay and ELISA was fair to poor ( К = 0 25) but since its range include values 
below 0 the relation between the data obtained by the bioassay and the competition ELISA 
can be explained by chance alone The serological data did not reveal a correlation be­
tween immunoprecipitation of Pfs230 and TB-activity. 
INTRODUCTION 
Malaria is transmitted from man to mosquito through gametocytes that develop in 
the blood of infected patients and are taken up by the female mosquito when taking a 
bloodmeal. Gametocytes of P.falciparum synthesize molecules of apparent Mr on SDS-
PAGE of 230 kDa and 48/45 kDa (Pfs230 and Pfs48/45), which remain exposed on the 
surface of macrogametes and zygotes [10,23,25] These molecules and a surface molecule 
of apparent Mr of 25 kDa (Pfs25) presented on developing zygotes, retort cells and 
ookinetes are the targets of mAbs some of which can block the subsequent differentiation 
of the sexual stages in the mosquito; this is defined as TB-immunity [20,21,23] TB-anti-
bodies are found in sera from people exposed to natural malaria and are - at least in part -
associated with immunoglobulin reactivity of these sera [13,14]. 
The conventional bioassay of ТВ-activity is based on development of oocysts in 
mosquitoes after membrane feeding of gametocytes as described by Vermeulen et al. [23]. 
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It is a costly, labour intensive assay thus limiting the number of sera that can be tested 
Development of a serological test predicting ТВ-activity would greatly simplify the study 
of the significance of ТВ-immunity A number of studies indicate that antibody responses 
to epitopes of Pfs48/45 and Pfs230 are part of the response observed after several malaria 
episodes [4,6,7] and that some epitope regions are conserved in many isolates [5] Immun-
oprecipitation with sera from people living in endemic areas precipitated radio-iodmated 
Pfs48/45 and Pfs230 In Papua New Guinea sera there was a good correlation between 
ТВ activity and antibody response to 125I labelled Pfs230 although no such correlation was 
found for the Pfs48/45 antibody reactivity [6] Among the Sri Lanka sera no correlation 
was found between ТВ-activity and the presence of antibodies to Pfs230 as detected by 
immunoprecipitation of radio-iodinated gamete proteins [19] 
In the present study a Pfs230 enriched fraction from gametocytes was used for the 
production of anti Pfs230 mAbs and development of ELISAs Competition ELISAs using 
different HRPO labelled mAbs, immunoprecipitations and Western blot analysis were 
developed to characterize antibody reactivity to various epitopes of Pfs230 in sera collec­
ted from gametocyte carriers Reactivity in the competition ELISA was compared to TB-
activity in the bioassay to analyze a possible predictive value of the competition ELISA 
for TB-activity 
MATERIALS AND METHODS 
Parasites 
Mature gametocytes of Ρ falciparum (isolate NF54) were produced in an automated 
large-scale culture system as described by Ponnudurai et al |16] Mature gametocytes 
were isolated at 37UC to prevent gametocyte activation as follows Parasite culture was 
diluted ten fold in M199, containing 0 1% glucose (M199-G) After centnfugation for 15 
minutes at 2,000g the pelleted parasites were resuspended in M199-G, loaded on a cushi­
on of 18% Nycodenz and centnfuged for 30 minutes at 5,000g as described by Vermeulen 
et al |23] The purified gametocytes were used a) directly, for SIFA, b) allowed to 
exflagellate to collect macrogametes and zygotes for use as dried antigen in IFA, or c) 
stored at -70°C until used for extraction of Pfs230 
Macrogametes and zygotes were purified and used for surface radio ìodination and 
immunoprecipitation as described by Vermeulen et al |23] 
The Pfs230 enriched aqueous phase (AP) extract of gametocytes 
Gametocytes suspended in 140 mM NH4C1 in 10 mM Tns/HCI (pH 7 4) were 
incubated on ice for 5 minutes to lyse the erythrocyte membrane and parasites were 
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pelleted by centnfugation (5 minutes, 16,000g at RT) Parasites were solubilized in 2% 
TX-114 in a 10 mM Tns/HCl buffer (pH 7 4) containing 1 mM PMSF at 4°C as descri­
bed by Bordier [2] and Kumar [9] The aqueous phase (AP) and detergent phase (DP) 
obtained by this method were collected separately The AP (Pfs230 enriched antigen) was 
dialysed against 0 1 M NH„HC03 and freeze-dned in ahquots equivalent to 2xl0
7
 gameto 
cytes 
Sera 
Field sera 46 sera were collected from gametocyte carriers (aged between 6-36 years) 
recruited at a dispensary in Yaounde, Cameroon [22] 
Positive control Serum of a Dutch expatriate who worked in an endemic malaria area in 
Tanzania for more than 30 years (Stl) This serum was positive in all tests used 
Negative control A panel of individual serum samples and a pooled sample of these sera 
(N56) were obtained from Dutch bloodbank donor volunteers, with no previous 
history of malaria 
Complement Freshly obtained AB-blood from Dutch bloodbank donors with no previous 
malaria exposure was allowed to clot at room temperature for 1 hour and aliquots of 
the pooled serum were stored at -70°C until required Freshly thawed samples were 
used as a source of complement 
Rabbit a-PLL serum Rabbit anti-poly L lysine serum was a gift from Dr Ρ Rotmans, 
Laboratory of Parasitology, University of Leiden, The Netherlands 
Monoclonal antibodies 
The Pfs230 specific mAb 28F1 has been described by Vermeulen et al |23,25) 
M Ab 18F25 was produced and characterized as described by Vermeulen et al [Ti\ 
MAbs ПЕЗ, 12F10, 4Н2, 12B3 and 14G8 all reacting with Pfs230 were a kind gift of Dr 
R Carter, Division of Biological Sciences, Edinburgh, England 
For the preparation of new mAbs freshly isolated aqueous phase from a TX-114 
extraction (AP), equivalent to 2 χ IO7 parasites in 50 μ\ PBS, was emulsified in 50 μΙ 
Freunds Complete Adjuvant and injected intrapentoneally in BALB/c mice The mice 
were boosted twice with AP in Freunds Incomplete Adjuvant Serum samples were tested 
by ELISA (see below) and on Western blots with gametocyte proteins Mice were killed 
three days after the last boost, spleen cells were fused with myeloma cells (P3/X63-Ag8 -
653) and suitable hybndomas were selected as described in more detail by Vermeulen et 
al [23] The supernates were screened for antibody reactivity in a) an IFA using air-dried 
sexual stage parasites, b) SIFA and c) a one-site ELISA using AP as antigen (see below) 
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Positive wells were cloned twice by limiting dilution and further tested on Western blots 
and by immunoprecipitation (see below). Selected clones were further expanded and 
ascitic fluids were produced. ТВ-activity of ascitic fluid or its purified IgG preparations 
was determined in the bioassay (see below). 
Purification of monoclonal antibodies 
Ascitic fluid was de-fatted with silicon dioxide (Sigma S-5631) as described by Neoh 
et al. [15], the immunoglobulin (Ig) containing supernate was dialysed against 0 1 M 
NH4HC03 and freeze-dned in bottles or IgG was further purified using a semi-automated 
FPLC system (Pharmacia) equipped with a Protein-Α column (Pharmacia) The IgG 
preparation was mixed with buffer A (0.1 M Tns/HCl + 1 0 M Na2S04, pH 8.0) loaded 
on the column at a flow rate of 1 ml/minute and washed with buffer A for 8 minutes 
Subsequently, buffer В (0 1 M glycine/HCl pH 2.5) was added to obtain a gradient of 5% 
to 50% В in 15 minutes followed by elution with 100% В for 5 minutes The IgG contai­
ning fractions were pooled, dialysed against 0.1 M NH4HC03 and aliquots stored free-
ze-dned in bottles. All IgG subclasses including IgGl can be recovered under these 
conditions 
Surface immunofluorescence assay 
SIFA was performed with live macrogametes and zygotes All incubations were done 
at room temperature Briefly, 106 mature gametocytes in 50 μ\ M199-G were incubated 
with 50 μΐ FCS for 15 minutes (for activation and ex flagellation) A 50 μΐ antibody test 
sample was added and incubated for 15 minutes. After washing with PBS, the cells were 
incubated with 50 μ\ FITC-conjugated goat anti-mouse IgG (Cappel 55493) diluted in PBS 
with 0 05% Evans Blue for 10 minutes After two PBS washings, the cells were examined 
under a cover glass with vaseline-coated edges on a Leitz Ortholux fluorescence microsco­
pe (500x magnification) 
Transmission-blocking assay 
A bioassay, using membrane feeders to feed A.gambiae mosquitoes, was used to 
determine ТВ-capacity of serum samples [17,18,23] All samples were separately tested in 
the presence of active or inactivated complement; all measurements were repeated at least 
once Field sera were diluted threefold and mAbs or IgG preparation of the sera tenfold 
with negative human serum Twenty mosquitoes per feeder were dissected 7 days after 
feeding, the number of oocysts on the stomach wall counted and William's mean (adjusted 
geometric mean (GM)) oocyst number calculated [26] An experiment was considered 
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successful if at least 90% of the mosquitoes of the controls carried oocysts The adjusted 
GM was used to determine the reduction activity (R) according to the following equation 
T
c
 - T, where T, is the geometric mean for the test feeder 
R = χ 100% 
T
c
 and T
c
 is the geometric mean of 3 controls 
Because of assay variation only values over 85% were considered to be a positive trans­
mission-blocking result 
Immunopreapitation 
Macrogametes and zygotes were surface radio-iodmated by catalysed ìodination 
(isotope 125Iodine), solubihzed by NP40 and the extract used for indirect immunopreapi-
tation as described by Vermeulen et al [23] 
Labelling of the mAbs with HRPO 
Labelling of FPLC purified mAb with HRPO was performed using the periodate 
method with an input molar HRPO/IgG ratio of 4 according to Wilson and Nakane [28] 
The labels were dialyzed against PBS, supplemented with thimerosal (0 01 %) and FCS 
(1%) and the samples freeze-dned in bottles and stored at 4°C 
Enzyme-Unked-immunosorbent assays 
¡-Detection of Pfs230 
a) Microtiterplates were coated with PLL, washed with PBS and incubated with 
serial dilutions of AP in PBS Subsequently, free PLL binding sites were blocked by 
incubation with 0 2 mg/ml Rabbit a-poly-L-lysine Ig in PBS for 30 minutes Following 
three washes with PBS, the wells were incubated with 50 μΐ HRPO-labelled anti Pfs230 
mAb (2 iig/ml) for 2 hours After a washing step, plates were incubated with 60 μΐ TMB 
(0 25 mM 3,3',5,5'-tetra-methyl-benzidine, 0 7 mM H202, 0 1 M sodiumacetate pH 5 5) 
substrate solution for 20 minutes The enzyme reaction was stopped by adding 60 μΐ 4 N 
H2S04 and the optical density (OD) was determined on an ELISA-reader at 450 nm 
(Titertek Multiskan MCC/340) 
b) Two-site ELISAs were carried out as described by Vermeulen et al [24], Zavala 
et al [29] and Carter et al [3] Microtiterplates were coated with 50 μ\ of anti Pfs230-
mAb (10 Mg/ml) in PBS for 30 minutes Plates were washed three times with PBS and 
saturated with 5% FCS in PBS After incubation with AP extract the wells were incubated 
with HRPO-labelled anti Pfs230 mAbs, substrate and the absorbance read at 450 nm as 
above 
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II- Competition-ELISAs 
Pfs230 was captured from AP extract in microtiterplates as described above under la 
or lb After three washes with PBS, wells were incubated with a mixture of 30 μ\ test 
sample and 30 μ\ HRPO-labelled anti Pfs230 mAb for 2 hours Competition ELISAs were 
carried out using serial two fold dilutions of unlabelled anti-Pfs230 mAbs (ranging from 
31 - 4000 ng/ml) or human sera (ranging from 1/10 1/640) made up in PBS containing 
0 1 % FCS The plates were washed, incubated with substrate and the absorbance read at 
450 nm as above 
All incubations were carried out at room temperature The competition titer is 
defined as the dilution of the test serum that results in the same OD reading as the (com­
petition negative) control serum Sera with a titer > 1/20 are considered positive 
Comparison of the ТВ-assay and competition ELISA for sera 
The results of competition ELISAs and the bioassay were compared by a statistical 
test on agreement using kappa as the index of observed agreement f 1,12] The index 
kappa (K) was calculated from the observed and expected (chance distribution) frequencies 
on the diagonal of the 2x2 table of outcomes of the bioassay and ELISA (see Table IV) 
. Po (i-Po) 
The approximate standard error of К is SE(K) = / 
» n(l-P
e
)2 
where P0 is observed proportional agreement and 
P
e
 the expected proportional agreement by chance 
The approximate 95 % confidence interval is given by К ± 1 96 SE(K) 
The index of agreement К has a maximum 1 00 when agreement is perfect, a value of zero 
indicates no agreement better than chance Negative values indicate disagreement The 
guideline by Altman [1] was used to determine the strength of agreement 
RESULTS 
Detection and preservation of Pfs230 in gametocyte extracts 
Pfs230 was found to be exclusively present in the AP of the TX-114 extract which 
also contained trace amounts of other protein molecules such as 27 kDa, 16 kDa, 48/45 
kDa as detected by specific ELISAs and SDS-PAGE analysis (data not shown) 
Immunoreactivity of Pfs230 in the freshly prepared AP with mAbs 18F25 and 28F1 
as determined by one or two-site ELISA or on Western blot, decreased rapidly during 
further processing and storage After two cycles of freeze-thawing of a freshly prepared 
AP only 20% immunoreactivity was left with mAb 18F25 and no immunoreactivity at all 
with mAb 28F1 Pfs230 detection did not change using protein staining on SDS-PAGE 
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gels (data not shown). In addition, immunoreactivity of Pfs230 was lost during free-
ze-drying in PBS (increased salt concentrations generated during freeze-drying). Exposure 
to 10 times concentrated PBS or 1 M NH4HC03 solution led to an instantaneous loss of 
immunoreactivity in the one-site ELISA. Immune reactivity was preserved when AP was 
dialysed against 0.1 M NH4HC03, freeze-dried and stored at 4°C. Pfs230 immunoreactivi­
ty appeared to be stable for 6 to 8 weeks when stored in vacuo or under N2-gas and 2 
weeks only when stored under air or in solution. 
Immunoreactivity of Anti-Pfs230 mAbs and epitope mapping 
All mAbs including the newly developed 63F2A2 (IgG2a), 63F3C8 and 63F6D7 
(both IgGl) as well as 18F25, 28F1, 4H2, 12B3 and 14G8 (all IgGl) and 11E3 and 
12F10 (both IgG2a) reacted specifically with air dried gametocytes and the surface of 
freshly prepared live intact macrogametes and zygotes. All above mentioned mAbs preci­
pitated Pfs230 of 125I surface radiodinated gametes (data not shown). On Western blots of 
NP-40 extracts of non-labelled gametocytes, mAbs 63F2A2, 63F6D7, 12F10, 18F25 and 
11E3 recognized proteins of apparent Mr 230 kDa and 260 kDa under nonreducing 
TABLE I: Epitope recognition of anti-Pfs230 mAbs in the two-site ELISA. 
ΡΓϋ230 HRPO labelled second mAb 
capture mAb blot IgG 18F25 11E3 63F6D7 63F2A2 12FI0 ÖF3C8 28F1 
18F25 
11E3 
63F6D7 
63F2A2 
12F10 
63F3C8 
4H2 
12B3 
28F1 
14G8 
+ 
+ 
+ 
+ 
+ 
-
-
-
-
_ 
1 
2a 
1 
2a 
2a 
1 
1 
1 
1 
1 
-
-
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
-
-
+ 
+ 
-
+ 
nd 
nd 
+ 
+ 
+ 
+ 
-
-
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
-
+ 
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
-
-
-
-
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
+ 
-
+ 
Note (+) positive reaction; (-) no reaction; nd, not done; blot, immunoreaction on a Western blot; 
IgG, immunoglobulin subclass; A = Epitope region 
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conditions. The other mAbs (63F3C8, 14G8, 4H2, 12B3 and 28F1) showed no reactivity 
on Western blot (see Table I). 
Checkerboard titrations with various concentrations of labelled mAbs and AP were 
performed to establish optimal conditions for Pfs230 detection. Such concentrations of 
antigen and HRPO-labelled mAb were chosen that maximal reduction of the OD was 
obtained when small amounts of competing antibody were included in the test. Optimal 
conditions for the competition ELISA were considered to be present with >60% of 
maximal binding of HRPO-mAb and an OD reading of > 1.0. For mAbs 63F2A2 (0.3 
ftg/ml) and 63F6D7 (0.5 μ%Ιπ\\) equal concentrations of labelled mAb and the correspon­
ding non-labelled mAb at the 50% competition value was found. The HRPO-labelling 
method did not decrease the affinity of most mAbs. Only with mAbs 28F1 (1.0 versus 0.1 
μg/ml) and 63F3C8 (2.5 versus 0.25 μg/ml) was considerably less of the non-labelled, 
corresponding mAb needed for 50% competition, suggesting that the immunoreactivity of 
these mAbs was substantially reduced after labelling. 
TABLE II; Competition of mAbs in the one-site Pfs230 ELISA. 
Comp 
mAb 
18F25 
11E3 
63F6D7 
63F2A2 
12F10 
63F3C8 
4H2 
12B3 
28FI 
14G8 
18F25 
+ 
+ 
-
-
-
-
-
-
-
. 
11E3 
+ 
+ 
-
-
-
-
-
-
-
_ 
HRPO labelled 
63F6D7 
-
-
+ 
+ 
+ 
-
-
-
-
_ 
63F2A2 
-
-
+ 
+ 
+ 
-
-
-
-
_ 
mAb 
12F10 
-
-
+ 
+ 
+ 
-
-
-
-
_ 
63F3C8 
_ 
-
-
-
-
+ 
+ 
+ 
-
28F1 
_ 
-
-
+ 
-
-
-
-
+ 
note. ( + ) competition between labelled and nonlabelled mAb, (-) no competition between labelled 
and nonlabelled mAb; л = Epitope region 
The epitope specificity of each mAb was determined by a) using different capture 
and labelled mAbs in two-site ELISAs, and b) competition between labelled mAbs and 
various unlabelled mAbs in one-site competition ELISAs. None of the labelled mAbs 
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bound to Pfs230 when captured by the corresponding non-labelled mAbs. The results with 
both systems (Table I + II) suggest the presence of 5 distinct epitopes or epitope regions 
with two exceptions; a) when 12F10 was used to capture Pfs230 no reaction with any of 
the labelled mAbs could be found, whereas 12F10 reacted with Pfs230 captured by several 
other mAbs. This may indicate that coated mAb 12F10 cannot capture Pfs230. b) Compe-
tition between mAbs was independent of the use of the mAb in labelled or unlabelled 
form, except for 63F2A2. In the one-site ELISA, 63F2A2 competed with labelled 28F1, 
but labelled 63F2A2 did not compete with unlabelled 28F1. This may indicate that 
63F2A2 and 28F1 react with the same epitope but with a considerable difference in 
affinity. A tentative map of the 5 epitope regions is given in figure 1 
Fig 1 Epitope regions of 
Pfs230 identified with a 
series of monoclonal anti 
bodies tested in a one-site 
competition ELISA MAbs 
are either effective at bloc 
king transmission of infecti-
on to mosquitoes (TB + ) or 
ineffective (TB-) Competi-
tive interactions in the ELI 
SA are indicated as (—•), 
no competition (—» || ) or 
not tested (—»') The îso-
type of the mAb is given 
between parenthesis Reac-
tion with Pfs230 on We-
stern blot is given as positi-
ve (bl + ) and negative (Ы-) 
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Transmission-blocking activity of mAbs 
Ascitic fluid and/or purified IgG from the hybridomas were included in the 
transmission-blocking feeder assay in the presence of either active or inactivated com­
plement Figure 1, shows that 5 μ% of mAbs 11E3, 12F10 and 63F2A2 (all IgG2a) 
blocked transmission more than 99%, but only in the presence of complement. MAbs 
18F25, 63F6D7, 63F3C8, 4H2, 12B3, 28F1 and 14G8 (all being IgGl) did not reduce 
transmission irrespective of the presence of complement Thus, epitope analysis and 
transmission-blocking experiments show that both blocking and non-blocking mAbs 
reacted with the same epitope and also compete for binding to that epitope TB-activity 
correlates with the presence of the complement fixing IgG2a isotypes which are only 
available for 2 epitopes (see figure 1). 
Transmission-blocking activity in human field sera 
Forty-six sera from gametocyte carriers, heat inactivated at 56°C for 30 minutes, 
were tested in feeding experiments in the presence of active and inactivated comple­
ment. Nineteen (41.3%) out of these 46 sera consistently blocked transmission in the 
presence of complement Twelve of the 19 sera with a ТВ-activity, were again retested 
in the bioassay both in the presence of either active or inactivated complement. None of 
these 12 field sera showed a complement dependent transmission-blocking activity (data 
not shown). 
Pfs230-associated TB-activity 
All 46 sera of gametocyte carriers precipitated a molecule of apparent Mr on 
SDS-PAGE of 230 kDa from NP40 extracts of 125I surface radio-iodinated gametes and 
reacted with molecules of apparent Mr of 230 and 260 kDa on a Western blot of NP40 
extracts of non-labelled gametocytes under non reducing conditions (data not shown) 
These results also showed that the antibodies present in the sera of the gametocyte 
carriers to 125I labelled Pfs230 precipitated a variable amount of the Pfs230 band. Due 
to variation of the 125I labelling of various batches of parasites used for these analysis 
our technique only permitted a semi quantitative analysis and no correlation was found 
between antibody reactivity to '"I labelled Pfs230 and TB-activity. 
These 46 sera were further analysed in a two-site competition ELISA with 18F25 
as capture m Ab and HRPO-63F2A2 as label Figure 2 shows competition by a serial 
diluted positive (Stl) in comparison to a negative serum (N56). The negative serum did 
not compete with HRPO-63F2A2 for binding to Pfs230 The overall inter-assay varia­
ble in this test (6 times tested in duplicate) has an average deviation of the mean OD at 
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Fig 2 Optical densities at 450 nm with increasing serum dilutions in a two site 
competition ELISA MAb 18F25 was used to capture the Pfs230 molecule from 
the aqueous phase and HRPO-63F2A2 for competition with a positive (Stl) and 
negative (N56) human serum 
each dilution step of 0 12 (21%) The overall intra-assay variation resulted in an average 
deviation of the mean OD of 0 09 (12%) 
Seven different mAbs reactive to the 5 epitopes/regions of Pfs230 described above 
including the complement dependent ТВ mAbs 11E3 and 63F2A2, were labelled with 
HRPO to investigate their competition with antibodies in serum samples of gametocyte 
carriers in the two-site competition ELISA Table III shows that competition positive 
human field sera (6 out of 46) competed with all labelled mAbs ι e with all epito-
pes/regions available, with no exception either in the competition positive or negative 
sera No significant differentiation in antibody responses to the different Pfs230 epitopes 
was found Five of these 6 sera blocked transmission Serum 41 (see Table III), the only 
non-blocking serum reduced transmission in a complement dependent way 
The correlation between the ТВ-activity (positive >85%, negative < 85%) and the 
Pfs230 competition ELISA is depicted in Table IV Five (26%) serum samples were 
positive in the ТВ-assay and in the competition ELISA, 14 (30%) were negative in the 
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TABLE III, Percentage transmission-reducing activity (R) in the presence of active (AC) 
or inactivated (1С) complement and the epitope specific competition titer of 5 Pfs230 epitope 
regions in positive field sera from 46 Ρ falciparum gametocyte carriers 
R HRPO-labelled competing mAb 
Serum 
4 
19 
38 
39 
41 
48 
N56B 
str 
AC 
99 
100 
90 
96 
73 
89 
0 
100 
1С 
ndA 
98 
nd 
97 
18 
80 
0 
100 
18F25 
(1) 
160 
80 
80 
80 
40 
80 
-
320 
11E3 
(1) 
320 
40 
40 
80 
80 
80 
-
160 
63F2A2 
(2) 
80 
40 
40 
40 
40 
40 
-
160 
63F6D7 
(2) 
160 
80 
160 
160 
80 
160 
-
640 
63F3C8 
(3) 
80 
40 
80 
40 
40 
40 
-
80 
28F1 
(4) 
160 
80 
80 
80 
40 
40 
-
160 
14G8 
(5) 
640 
320 
nd 
320 
160 
160 
-
nd 
Note ( ) Titer < 1/40, ( ) epitope region, A = not done, " = a pool from Dutch blood donors with 
no history of malaria, c = a positive control serum which blocks transmission 
TABLE IV, Agreement between transmission-blocking activity (ТВ-assay) and Pfs230 
competition ELISA (C230-ELISA) of 46 sera from gametocyte carriers, Cameroon 
TB-assay 
>85% 
<85% 
Total 
No of C230-ELISA serum 
Positive 
5 
1 
6 
Negative 
14 
26 
40 
samples 
Total 
19 
27 
46 
Relative specificity = 26 of 27, or 96 3%, relative sensitivity = 5 ot 19, 
or 26 3%, Observed proportional agreement (5 + 26)/46 = 0 67, 
chance proportional agreement (6/46 χ 19/46) + (40/46 χ 27/46) = 0 57, 
observed minus chance agreement (0 67 - 0 57) = 011, 
maximum possible agreement beyond chance level (1 - 0 57) = 0 43, 
agreement quotient (kappa (K)), 0 11/0 43 = 0 25 
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competition ELISA but positive in the ТВ-assay, and 26 (56%) were negative in both 
tests The index of agreement between the outcomes of bioassay and the competition 
ELISA is К = 0 25, 95% confidence interval -0 06, +0 56 The index indicates (Altman, 
1991) that agreement is fair to poor and the negative value in the confidence interval 
indicates that agreement can be explained by chance The ELISA outcomes show a relati­
ve specificity of 96% (26 of 27) and a relative sensitivity of 26% (5 of 19) 
DISCUSSION 
A panel of monoclonal antibodies belonging to different IgG-subclasses were analy­
sed for Pfs230 binding and ТВ-activity All mAbs reacted in the indirect IFA with the 
surface of macrogametes and zygotes of Ρ falciparum and all immunoprecipitated Pfs230 
from NP40 extracts of surface radio-iodinated macrogametes and zygotes On Western 
blot prepared from gametocyte extracts, only mAbs 18F25, 11E3, 63F2A2, 63F6D7 and 
12F10 recognize Pfs230 under non-reducing conditions In addition, a protein of apparent 
Mr on SDS-PAGE of 260 kDa is also recognized on blots This difference between results 
obtained with immunoprecipitation and Western blot analysis has been described before 
[20] and is best explained by the intracellular localization of a higher Mr precursor of 
Pfs230 MAbs can also be subdivided by their ability to block transmission, ι e all IgGl 
mAbs were negative and IgG2a mAbs (11E3, 63F2A2 and 12F10) blocked transmission in 
a complement dependent reaction Complement dependent lysis of macrogametes and 
zygotes in vitro by Pfs230 mAbs has been described by Quakyi et al [20], and has also 
been found in the Ρ galltnaceum system [8] 
These mAbs were used for the development of a number of different ELISAs in 
order to construct an epitope map of Pfs230 (figure 1), to determine the presence of anti 
Pfs230 antibodies in field sera and to correlate presence of anti-Pfs230 antibodies in field 
sera with ТВ-activity of these sera as observed in the bioassay 
The Pfs230 antigen used in these ELISAs was prepared by Triton TX-114 gametocy­
te extraction and phase separation as described by Bordier [2] and Kumar [9] It appeared 
that immunoreactivity of Pfs230 in these extracts was lost upon storage in PBS solution, 
after freeze thawing or exposure to high salt concentration The use of aqueous solutions 
containing a volatile buffer for freeze-drying and storage in vacuo, prevented loss of 
immunoreactivity for periods of 2 months Loss of immunoreactivity of Pfs230 after 
exposure to high salt concentration has been observed before [11] The loss of immunore 
activity in solution suggests thai oxidative changes could be involved in conformational 
changes of Pfs230 However, storage of AP in the presence of either vitamin E or glutat 
hion did not prevent loss of immunoreactivity (data not shown) 
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One-site ELISAs could not be developed by direct coating of Pfs230 to the plates, 
but was realized by coating on a precoat of poly L-lysine or Pfs230 specific mAb The 
positive charge of poly-L-lysine most probably enables binding with the glutamate-nch 
Pfs230 [27] 
This panel of mAbs enabled the recognition of 5 different epitope regions on the 
Pfs230 molecule, each epitope being present only once Monoclonal antibodies allocated 
to two epitope regions (here designated 1 and 2) were able to react on a Western blot All 
mAbs of the complement fixing IgG2a subclass blocked transmission whereas none of the 
mAbs of the complement non-fixing IgGl subclass did not Thus, both ТВ positive and 
negative antibodies can bind to the same epitope and compete with one another for binding 
to that epitope MAbs to the three other regions (designated 3 to 5) did not block trans­
mission but these were all of the IgGl subclass 
In a panel of sera from gametocyte carriers from Cameroon all 46 sera immunopre-
cipitated Pfs230, and 19 sera exhibited ТВ-activity Sera were classified with respect to 
their capacity to immunoprecipitate Pfs230 by a semi-quantitative analysis of autoradio 
grams, compared to the results of the TB-bioassay this revealed no correlation (P-value 
= 0 396) None out of twelve sera showing ТВ-activity needed the presence of comple­
ment for this activity More sera need to be tested before definite conclusions can be 
drawn on the role of complement in ТВ-activity of human field sera 
Six sera of these gametocyte carriers from Cameroon were positive in the competiti 
on ELISA and this was independent of the epitope region analysed, indicating that there 
was no epitope restriction Five of these competition positive sera also blocked transmissi 
on in the bioassay, but 14 out of the 19 blockers were negative in the competition assays 
To compare the outcomes of ТВ-assay and ELISA a statistical test for comparison of 
proportions or association is not considered appropriate Besides sensitivity and specificity 
a measure of agreement is required rather than association The index of agreement kappa 
(K.) measures the amount of agreement beyond chance and can be used for the correlation 
analysis In gametocyte carriers the amount of agreement was fair to poor but since the 
confidence interval contains zero, this implies that the agreement can be explained by 
chance 
In summary, the Cameroon field sera exhibit a) absence of complement dependency 
of the ТВ-activity, b) reactivity with all available epitopes of Pfs230 analysed so far and 
c) no correlation between either the Pfs230 competition ELISA or immunoprecipitation of 
Pfs230 from NP40 gametocyte extracts and ТВ-activity as observed in the bioassay This 
raises the question whether under field conditions ТВ activity is Pfs230 mediated 
Our results are in contrast to results obtained in a series of Papua New Guinea sera, 
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where Graves et al. [6] observed a correlation between immunoprecipitation of Pfs230 and 
reduction of infectivity to mosquitoes. In our hands all the Cameroon sera precipitated 
Pfs230 and a semiquatitative analysis on autoradiograms revealed no correlation with TB-
activity. One aspect is the difference in study populations. A parallel study analysing TB-
activity and antibody reactivity against Pfs230 as determined by immunoprecipitation in a 
Sri Lanka population failed to show this correlation [19]. Our data do not exclude the 
possibility that Pfs230 mediated ТВ-activity might be present in field sera which is com­
plement independent. Another important question is to find out whether Pfs230 mediated 
ТВ-activity is always complement dependent. 
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ABSTRACT 
Using the parental hybridoma cell line 63F2A2 that produces specific antibodies of 
isotype IgGl (63F2A2.1) against Pfs230 we attempted to enrich for hybridoma's synthesis 
downstream switch variants' IgG2b (63F2A2.2b) and IgG2a (63F2A2.2a) monoclonal 
antibodies (mAbs). The parental IgGl did not reduce the P.falciparum transmission in a 
bioassay irrespective of the presence of complement. MAbs 63F2A2.2b and 63F2A2.2a 
were effective in reducing the infectivity of P.falciparum parasites to A.gambiae mosquit-
oes in membrane-feeding experiments. A transmission-reduction of 91% was accomplished 
by the 63F2A2.2b switch variant and greater than 99% reduction by the 63F2A2.2a 
switch variant, but only in the presence of active human complement. Subsequently, the 
transmission reducing effect of mAb 63F2A2.2b or 63F2A2.2a was confirmed in vitro by 
the rapid lysis of newly formed macrogametes/zygotes in the presence of active comple-
ment. MAb 63F2A2.1 did not lysed the newly formed macrogametes/zygotes irrespective 
the presence of complement. 
INTRODUCTION 
Malaria is transmitted from man to mosquito through gametocytes that develop in 
the blood of infected patients. Gametogenesis of P.falciparum in the Anopheles mosquito 
midgut is accompanied by the emergence of the gametocyte from the red blood cell. From 
this moment the extracellular parasites become susceptible to immune factors such as 
antibodies and complement, taken up during the bloodmeal from the vertebrate host [4]. 
Gametocytes of P.falciparum synthesize molecules of apparent Mr of 230 kDa and 
48/45 kDa molecules (Pfs230 and Pfs48/45) after extraction with sodium dodecyl sulfate 
(SDS) and separation on SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Both 
molecules are expressed on the surface of macrogametes/zygotes. Several monoclonal 
antibodies (mAbs) reactive to these sexual stage molecules block transmission of the 
parasites from the vertebrate host to the mosquito vector. Some of these mAbs suppress 
infectivity of malaria gametocytes to mosquitoes in the presence of active human comple-
ment [8,16,19,21,22]. To answer the question whether 63F2A2 mediated transmission-
blockade is isotype or epitope dependent, a number of isotype switch variants were 
prepared and selected for differences in their capacity to fix complement. 
Downstream isotype switch variants occur spontaneously in hybridoma cell lines 
with identical binding sites differing only in heavy-chain isotype [10,11]. The frequency of 
spontaneously occurring isotypic switch variants vary from 106 to lOVcell/generation 
[10,17] and a sensitive assay is needed to detect the switched Immunoglobulin (Ig) isotype 
amid a large amount of Ig of the parental isotype. The technique of sequential sublining 
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combined with screening by isotype specific ELISA has been proven before to be succes­
sful [2, Π J-
In this study the importance of IgG subclass for transmission-blocking activity is 
further analysed by production and testing of a number of switch variants of anti-Pfs230 
specific mAb 63F2A2. 
MATERIALS AND METHODS 
Parasites and Pfs230 extract 
Mature gametocytes of P.falciparum (isolate NF54) were produced in an automated 
large-scale culture system as described by Ponnudurai et al. [12|. Gametocyte isolation 
and Triton X-114 (TX-114) extraction of the Pfs230 was obtained as previously described 
[21]. The freeze-dried aqueous phase extract was diluted in phosphate buffered saline 
(PBS) and used as the antigen in both the competition and the one-site Pfs230 ELISA. 
Antibodies 
1) The anti-Pfs230 mAbs 18F25, 63F2A2 (63F2A2.1) and 63F3C8 (all isotype 
IgGl) and anti-Pfs25 mAb 32F81 (isotype IgGl) have been previously described 121,22]. 
MAb 18F25 was labelled with horseradish peroxidase (18F25-HRPO) according to the 
periodate method described by Wilson and Nakane [24]. The labelled mAb was dialysed 
against PBS, thimerosal (0,01%) and fetal calf serum (FCS, 1%) added and samples were 
stored at 4°C. MAb 32F81 was labelled with fluorescein isothiocyanate (32F81-FITC) 
following the method described by Goding [5]. Monoclonal rat antibodies against different 
mouse Ig isotypes (RaAM-isotype) IgGl, IgG2a and IgG2b and HRPO labelled monoclo­
nal rat-anti-mouse kappa light-chain antibodies (RaAM-k-HRPO) were purchased from 
CLB (Amsterdam, the Netherlands). 
2) Complement: AB-blood from Dutch bloodbank donors, with no previous malaria 
exposure was allowed to clot at room temperature for 1 hour and aliquots of the pooled 
serum were stored at -70°C until required. Freshly thawed samples were used only ones 
as a source of complement. The serum was heated at 56°C for 30 minutes to inactivate 
complement activity. The serum was also used as a malaria negative control serum in the 
transmission and parasite lysis tests. 
Selection, enrichment and purification of isotype switch variants 
Selection and enrichment of isotype switch variants were conducted by the technique 
of sequential sublining [2,11]. Briefly, the parental 63F2A2.1 hybridoma cells were grown 
in a 96 well microliter plate (NUNC, Intermed) containing 1,000 cells per well, in Dul-
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becco's Modified Eagles Medium supplemented with 20% FCS and 2 5 units interleukin 6 
per ml and cultured in a humidified 5% C02-in-air-incubator at 37°C After 7 days the 
culture supernatants were tested in the isotype-specific ELISA and cells from positive 
wells were redistributed at 50 cells per well After a culture period of 4 days the superna 
tants were tested, cells of positive wells subcultured at 2 cells per well and cloned by 
limiting dilution Supernatants were tested for the presence of the parental isotype and/or 
switch variants 
Selected cloned lines were expanded in culture and ascitic fluids were produced from 
106 hybridoma cells injected in pnstane primed BALB/c mice IgG was purified from 
ascitic fluid using a semi-automatic FPLC system (Pharmacia) equipped with a Protein-A 
column (Pharmacia) as previously described |21] 
Enzyme-Linked Immunosorbent Assay's (ELISAs) 
a) The Isotype-specific ELISA was used as previously described by Boot et al [2] 
The reliable ELISA detection limits were 5 ng/ml for IgGl, IgG2b or IgG2a using stand­
ard IgG isotype controls Possible crossreactivity between isotypes was below 0 1 % 
b) A specific one-site ELISA for detection of antibodies against Pfs230 was carried 
out as previously described [21] 
All incubation steps were done at room temperature except overnight incubations, 
which were done at 4°C Between the different steps, plates were washed three times 
using PBS The ELISAs were performed in duplicate and the mean value of the ODs was 
used for analysis 
Transmission-blocking assay 
The effect of m Abs on the infectivity of Ρ falciparum to A gambiae mosquitoes was 
tested in a bioassay, using membrane feeders as previously described [13,14,22] Briefly 
while keeping the temperature at 37°C, 14 day old cultures containing fertile gametocytes 
were mixed with prewarmed uninfected red cells and mAbs, introduced in prewarmed 
feeders, and fed to A gambiae mosquitoes All mAbs were separately tested in the feeder 
assay in the presence of active or inactivated human complement Fully engorged mos­
quitoes were separated and held at 26"C Mosquitoes were dissected seven days after 
feeding, the number of oocysts, in the mosquito midgut, was counted and William's mean 
(adjusted geometric mean (GM)) oocyst number calculated [23] The adjusted GM was 
used to determine the reduction activity [21| and values greater than 85% were consistent 
in subsequent experiments 
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Suspension Immunofluorescence Assay (SIFA) 
Molecules with an apparent M
r
 on SDS-PAGE of 25 kDa (Pfs25) appear on the 
surface of macrogametes/zygotes some hours after zygote formation and this was used as 
a marker of the further development of sexual stages in vitro or in the mosquito midgut 
(feeder assay, see above) 
Suspensions of 106 mature gametocytes in 100 μί RPMI 1640 medium were mixed with 
100 μί negative serum, 30 μί active or inactivated complement serum and 10 μί mAb 
63F2A2 parental or the respective switch variants (5 or 25 μg in PBS) and incubated at 
27°C for 3 hours Subsequently 25 μί of the suspension containing 105 parasites was 
added to 25 μί 32F81-FITC 1 40 diluted in 0,05% Evansblue in PBS pH 7 2/2% glucose 
(0 1 M)/0,1 % Na2EDTA (2 7 mM)/0,05 % NaAz (PBG) The parasites were incubated for 
1 minute, washed with phosphate buffered glucose solution containing 5% bovine serum 
(PBGB), centnfuged at 16,000 g for 10 seconds, resuspended in 30 μ\ PBGB, placed in a 
Burker Turk counting chamber and Pfs25 positive macrogametes/zygotes were counted 
under a Leitz Ortholux fluorescence microscope (x500 magnification) 
Isotype dependent lysis of macrogametes/zygotes 
One hundred μί suspension containing 106 vital mature gametocytes in RPMI 1640 
medium was mixed with 100 μί negative serum and incubated at 27°C for 30 minutes 
Twenty-five μί of this suspension was incubated with 25 μί 18F25-FITC for 20 minutes, 
washed with PBGB by centnfugation at 16,000 g for 10 seconds and the pellet was 
resuspended in 30 μί PBGB To this sample 5 μί (1 μg) of the mAb 63F2A2 switch 
variant was added together with 4 μί serum as a source of active or inactivated compie 
ment Parasites were examined and scored as intact or lysed macrogametes/zygotes using 
both fluorescence and phase contrast light microscopy (x500 magnification) 
RESULTS 
Isolation and characterisation of switch variants 
When seeded at 1,000 cells per well, IgG2b switch variants were detectable from the 
parental 63F2A2 1 hybridoma after 7 days of culture in 1 2 wells per microtiter plate 
Further cloning and subcloning resulted in the isolation of a 63F2A2 switch variant of the 
IgG2b subclass (63F2A2 2b) Using a similar protocol 63F2A2 mAbs of the IgG2a isotype 
(63F2A2 2a) were obtained from the 63F2A2 2b producing hybridoma All switch van 
ants were subjected to limiting dilution conditions to reach purity at clonal level The 
switch variants reacted only in the ELISA that was specific for the particular isotype (data 
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OD (450 η m) 
jsotype switch variant in ng/ml 
Fig 1 Reactivity of IgGl, IgG2a and IgG2b isotype variants of mAb 63F2A2 in 
the one-site Pts230 ELISA Protein-Α purified mAbs were serially diluted 
ranging from 10 /xg/ml to 0 12 ng/ml in PTG Results are expressed as the 
mean of duplicate incubations 
not shown) Figure 1 shows similar binding profiles of the parental mAb 63F2A2 1 and its 
IgG2b and IgG2a switch variants in the Pfs230 one site ELISA 
Transmission-blocking capacity of isotypes 
The effect of IgG subclass specificity on transmission was analysed in the bioassay 
in the presence of active or inactivated human complement In the presence of active 
complement, anti-Pfs230 mAbs 63F2A2 2b or 63F2A2 2a suppressed infectivity of Ρ 
falciparum to mosquitoes by >90% and >99% respectively at concentrations of 10 
μg/feedeг (Table 1) In the presence of inactivated complement the different isotypes of 
mAb 63F2A2 had no significant effect relative to the mean of the three controls MAb 
63F2A2 1 did not reduce oocyst number, irrespective of the presence of complement 
Oocyst numbers of the control group with active complement were not significantly 
different from those in the data of the inactivated complement group (paired samples t 
test i=0 56, degrees of freedom (df)=28, P=0 58) 
Table 2 shows dose-dependent reduction of oocyst numbers in the presence of mAb 
63F2A2 2b or 63F2A2 2a at concentrations varying from 0 2 to 25 μg/feeder (0 8 to 100 
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fig/ml). Even at a concentration of 0.2 μ% mAb 63F2A2.2a / feeder the geometric mean 
number of oocysts was 0.9 with a SD of 0.3 in the presence of active complement which 
result in a reduction activity of 80%. In several independent experiments the reduction 
capacity of mAb 63F2A2.2b was lower than mAb 63F2A2.2a. 
TABLE 1. Effects of different isotypes of anti-Pfs230 mAb 63F2A2 on infectivity of 
P.falciparum gametocytes to A. gambiae mosquitoes in membrane feeding experiments 
with active or inactivated complement. 
mAb Oocyst count8 
63F2A2 CA Experiment 1 Experiment 2 
isotype 
1 
1 
2b 
2b 
2a 
2a 
control1 
+ 
-
+ 
-
+ 
-
GMW 
24.3 
20.7 
3.2 
21.7 
0.2 
27.2 
32 2 
SD 
5 9 
3.6 
0.7 
4.5 
0.1 
3.3 
6.5 
R 
24 5 
35.7 
90 1 
32.6 
99.4 
25.6 
P/D 
20/20 
20/20 
18/20 
20/20 
4/20 
20/20 
58/59 
GMW 
2.9 
2.7 
0.2 
2.4 
0 
3.3 
2.8 
SD 
0.9 
1.1 
0.1 
0.8 
0 
1.1 
1.4 
R 
0 
5.6 
93.9 
14 3 
100 
0 
P/D 
24/24 
27/30 
5/20 
14/20 
0/20 
24/30 
51/59 
л
 = active ( + ) or inactivated (-) human complement, B = The data of experiment 2 
are the combined results of two independent tests; c = Control is the mean of three 
feeders per experiment. 
GMW, William's mean oocyst number (adjusted geometric mean (GM)); SD, Standard 
deviation of the GMW; R, Reduction activity according to the equation R = (TC - T, )/Tc 
χ 100% where T, is the GM tor the test feeder and T
c
 is the GM of the three controls; 
P/D, The number of oocyst positive mosquitoes / number dissected. 
Next, twentyfive anti-Pfs230 m Abs of IgGl, 2b or 2a in the form of heat inactivated 
mouse ascites (final dilution 1:27), provided by Dr R. Carter [18] or developed by one of 
us (N.K.), were tested for their infectivity of P.falciparum gametocytes to mosquitoes. 
Ten anti-Pfs230 mAbs (isotype IgG2a) and one of isotype IgG2b (mAb 12A1A5) were all 
effective in blocking the transmission but only when active complement was added to the 
feeder whereas fourteen IgGl isotype mAbs did not (Table 3). 
47 
Chapter 3 
TABLE 2. Infectivity of P.falciparum gametocytes to mosquitoes of anti-Pfs230 mAb 
63F2A2.2b or 63F2A2.2a at various concentrations with active or inactivated complement. 
^fjtted/er 
25 
25 
5 
5 
1 
1 
0.2 
0.2 
control 
С 
+ 
-
+ 
-
+ 
-
+ 
-
GMW 
3.2 
20.7 
3.0 
24.2 
9.5 
27.3 
32.2 
mAb 63F2A2.2b 
SD 
0.7 
3.6 
0.7 
4.3 
2.1 
6.1 
6.5 
R 
90.1 
35.7 
90.7 
24.5 
70.5 
15 2 
Oocyst 
P/D 
18/20 
20/20 
17/20 
21/21 
19/20 
20/20 
ND 
ND 
58/59 
count 
GMW 
0 
4.3 
0.1 
3.3 
0.1 
4.5 
0.9 
4 7 
4.5 
mAb 63F2A2.2a 
SD 
0 
1.1 
0.1 
1.0 
0.1 
1.3 
0.3 
1.6 
1.3 
R 
100 
4.9 
99.8 
27.0 
99.8 
0 4 
80.1 
0 
P/D 
0/20 
18/20 
2/20 
16/20 
2/20 
17/20 
12/20 
16/20 
46/59 
See legend of Table 1 for explanation of the different items. ND: not done 
TABLE 3. Effect of anti-Pfs230 mAbs in the presence of active complement on infectivity 
of P.falciparum gametocytes (isolate NF54) to A.gambiae mosquitoes. 
mAb Isotype RA Source8 
5A8, 12C5, 8C10, 9C3, 4H2, 12B3, 14G8, 8D9 
7E10H7, 9F2A10, 14D7, 14H10A2, 13H10E1, 2G8E5 
11E3, 12F10, 1H2, 3G9, 7A6, 8C11, 17E9, 4C10 
12A1A5, 11C12F7, 21C1 
A
 = percentage oocyst reduction in the transmission-blocking assay. See for formula the legend of 
table 1, footnote B; B = Anti-Pfs230 mAbs provided by (I) Dr. R Carter (18) and (II) developed 
by Dr. N. Kumar; c = MAb 12A1A5 has an IgG2b isotype. 
IgGl 
IgGl 
IgG2a 
IgG2aL 
0-24 
0 - 3 5 
100 
100 
I 
II 
1 
II 
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Х//Л lgG2b 
I ] lgG2a 
Inactivated Active 
Human Complement 
Fig 2. Effect of different isotypes of mAb 63F2A2 on the in vitro development 
of macrogametes/zygotes as detected by the number of Pfs25 positive macroga-
metes/zygotes per μ\. 
SIFA and complement-mediated lysis of macrogametes/zygotes 
The mechanism of complement-dependent transmission-blocking activity of mAbs 
63F2A2.2b and 63F2A2.2a was further analysed in vitro with activated gametocytes and a 
SIFA based on antibody reactivity to Pfs25 thereby monitoring development of macroga­
metes/zygotes 3 hours after activation. The actual number of macrogametes/zygotes differs 
in several parasite-batches which makes direct comparison of data of independent experi­
ments impossible. In a representative experiment (Figure 2), no statistical significant 
differences were found in macrogametes/zygotes numbers between the different isotypes 
and the controls (no mAb added) when inactivated complement was added (e.g. paired 
samples t test between IgG2a and control: t =1.37, degrees of freedom (df)=2, P= 
0.305). In addition, no significant difference was found between the number of macroga­
metes/zygotes for the control groups (absence of specific anti-Pfs230 mAb) with active 
complement in comparison to inactivated complement (t =4.13, df=2, P=0.054). When 
the data of the control and the IgGl group are compared with respect to the effect of 
complement a significant reduction was observed in the presence of active complement (t 
=4.43, df=5, /'=0.007). Active complement in the presence of mAb 63F2A2.1 had no 
J U U 
200 
100 -
I. 
ж /// 
τ 
ί 
ж '7//^ 
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effect but in the presence of mAb 63F2A2.2b or 63F2A2.2a the number of macrogame-
tes/zygotes was reduced substantially and almost completely in comparison to the effect of 
the control group (t =6.62, df=2, P=0.022 and t =6.47, df=2, P=0.023 respectively). 
Lysis of macrogametes/zygotes by the complement fixing mAb 63F2A2.2a in the 
presence of active or inactivated complement is shown in fluorescent microscope micro­
graphs using SIFA and the FITC-labelled anti-Pfs230 mAb 18F25 (Fig. 3). In the absence 
of lysis fluorescence was clearly visible at the circumference of apparently intact parasites 
(Fig. ЗА) whereas fluorescence after lysis either revealed no round forms or damaged 
round forms with fluorescent debris or fluorescence of incomplete round forms (Fig. 3B). 
Using phase contrast light microscopy, damaged parasites manifested with an extrusion of 
the pigment or localization of aggregated pigment at peripheral sites and loss of pigment 
motility. 
Fig 3. Complement mediated lysis of early P. falciparum macrogametes/zygotes in 
the presence of mAb 63F2A2.2a as observed after staining with mAb 18F25-FITC. 
The macrogametes/zygotes remained visually intact (A) when incubated with IgG2a 
switch variant in the presence of inactivated complement and were lysed (B) in the 
presence of IgG2a switch variant and active human complement. 
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DISCUSSION 
In the present study downstream IgG2b and IgG2a switch variant antibodies specific 
for Pfs230 were generated from the parent mAb 63F2A2.1. In contrast to 63F2A2.1, both 
63F2A2.2b and 63F2A2.2a were able to block the transmission of Ρ falciparum to A gam-
biae mosquitoes in membrane feeding experiments but only in the presence of active 
complement. Results from the one-site Pfs230 ELISA (Fig. 1) show that the dose depen­
dent binding of mAbs 63F2A2.1, 63F2A2.2b and 63F2A2.2a to Pfs230 is comparable. 
SIFA results suggest a complement dependent disturbance of the sexual development of 
macrogametes/zygotes after binding of 63F2A2.2b or 63F2A2 2a switch variant mAbs. 
Even in the presence of active complement the parental mAb 63F2A2.1 did not prevent 
the development of parasites after activation of the mature gametocytes, however, irre­
spective the presence of these mAbs, active complement shows a direct effect on macroga­
metes/zygotes development (Fig. 2) This may be explained by an alternative activation of 
the complement cascade due to a direct interaction between C3 and the parasites, similar 
to the stimulation observed with certain bacteria. Although some reduction in the number 
of viable parasites is accomplished by this activation of the alternative pathway of comple­
ment, this does not lead to transmission-blockade Whether this phenomenon applies to 
other epitopes of Pfs230 [21] remains to be determined 
All anti-Pfs230 mAbs of isotype IgG2b or IgG2a tested so far were effective in bloc­
king the transmission but only when complement was added to the feeder whereas IgGl 
isotype mAbs did not So far there is an absolute correlation between Pfs230-related trans­
mission-blockade by mAbs, the ability of the isotype to fix complement and the need for 
active complement in order to show transmission-blockade by Pfs230-binding antibodies 
Quakyi et al. |16| already described two Pfs230 specific mAbs (both IgG2a) that sup­
pressed infectivity of Ρ falciparum to Afreeborni mosquitoes by a complement mediated 
lysis of early macrogametes/zygotes. A comparable effect of complement fixing mAbs of 
the IgG2a isotype against a P.gallmaceum protein that is analogous to Pfs230 was descri­
bed by Kaushal el al. [8] Confirm our observations, Read et al. [18] found in a recent 
study also the complement dependent suppresion of gametocytes of P.falciparum 3D7 to 
mosquitoes with anti-Pfs230 mAbs of isotype lgG2a. 
Generally, mouse IgGl is known to be a poor binder of human complement factor 
Clq, whereas IgG2b and IgG2a bind Clq effectively Binding of Clq is the first step in 
activation of the classical complement cascade, leading to the formation of the membrane 
attack complex. Mouse lgG2a is more effective than IgG2b in fixation of human comple­
ment factors such as Clq, C4b and C3b [3,9] Although complement fixation in binding 
tests is not directly proportional to complement activation, haemolysis experiments suggest 
51 
Chapter 3 
that the fixation of C3b is directly proportional to activation of C3b and the terminal lytic 
sequence [3] The capacity of different murine isotypes to fix complement, perfectly fits 
the ability of mAb 63F2A2 switch variants to interfere with complement 
These results may have important implications for the study of anti-Pfs230 antibodies 
that are present in 40-85% of the endemic human sera [6,20] The presence of anti-Pfs230 
specific antibodies in field sera has been associated with transmission-blocking activity by 
some investigators [6] but could not be confirmed by others [15] or in our study [21] 
Immunoprecipitation and ELISA [6,21] are based on epitope recognition by antibody 
being independent of the isotype while a Pfs230 based transmission-blockade may be 
accomplished by an isotype dependent effector mechanism When Pfs230-components are 
used in the design of a transmission-blocking vaccine [16], these findings support the need 
for an immunization strategy [1,7] which should induce antibodies of a complement 
binding isotype 
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ABSTRACT 
Monoclonal antibodies (mAbs) and human sera from gametocyte carriers were applied 
in the bio-assay to test for their transmission-blocking capacity. 
Competition ELISA's have been developed for the detection of natural transmission 
blocking antibodies. Approximately 55% of the sera blocking in the bio-assay gave 
positive results in these competition ELISA's. 
INTRODUCTION 
Gametocytes and macrogametes/zygotes of Ρ falciparum synthesize 230 kDa and 
48/45 kDa molecules [7]. Several transmission-blocking mAbs had been described which 
react specifically with these proteins of the sexual stages of P.falaparum [3,4,5]. Both 
surface proteins (Pfs230, Pfs48/45) are also target antigens of natural transmission-
blocking (ТВ) immunity [2]. As their epitopes seem to express a conformational configu­
ration, peptide-constructs cannot be used as immunogens for transmission-blocking 
antibodies. 
The main objective of the present study was to develop a reliable method for the 
assessment of transmission reducing antibodies in sera of people exposed to malaria 
infections. Reduced transmission as demonstrated using the laborious bio-assay with 
A gambiae was considered the standard 
RESULTS AND DISCUSSION 
Solubilizing the antigens from gametocytes to make it suitable for applications in ELISA. 
Gametocytes were extracted with Triton X-114 (TX-114) as described by Bordier [1] 
Phase separation of Triton X-114 extracts results in the separation of Pfs230 in the 
aqueous phase (AP) and Pfs48/45 in the detergent phase (DP) Immune reactivity ot 
Pfs230 was preserved for at least 8 weeks after freeze-drying and storage under vacuum 
or under Nj, and Pfs48/45 over one year if stored at -80°C 
No Pfs230 was detected with the a-Pfs230 mAbs after directly coating of AP onto the 
surface of the ELISA-plate. After precoating with poly-L-lysine before coating with АР a 
one-site ELISA using HRPO-coupled rabbit-anti-mouse conjugate to detect binding of the 
mAbs could be established. With the DP only a two-site ELISA could be done. 
Epitopes of the sexual antigens 
In studies using several mAbs with specificity for each of both proteins, it has been 
established that each protein has more than one epitope, but per molecule of protein each 
epitope is expressed only once Some of these epitopes interact with blocking others with 
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non-blocking mAbs as observed in the bio-assay. Also it became evident that the simulta­
neous presence of more than one of these protein specific antibodies, interacting with the 
same protein, might cause potentiation of the blocking effect. 
MAbs against the 230 kDa protein of hte IgG2a isotype, made by Dr R. Carter, 
appeared to give a complement dependent blockage by lysis of the macrogametes. The 
relevance of this phenomenon in sera from endemic areas is presently under study and 
point to a role for isotypes 
In one-site competition ELISA's we have checked all available Pfs230 mAbs against 
each other At least 5 singly expressed epitopes have been defined on Pfs230. Three are 
targets of mAbs with no transmission-reducing activity The other two are defined through 
its reactivity with transmission-reducing and nonreducing mAbs. 
The two-site ELISA now appeared utilizable for testing material in epidemiological 
settings for the testing of specificity to Pfs230 next to that of Pfs48/45. 
Pilot study on the relevance of the test for field samples 
In view of the epitope results with the mAbs further studies were made with a positive 
serum, negative sera and a panel of 46 sera taken from gametocyte carriers in an endemic 
area 
The positive serum (Stl) collected from a missionary who worked for thirty years in 
Tanzania, was positive in all assays, blocked transmission in the bio-assay and was used 
as a reference serum A pool of negative sera (N56) was obtained from Dutch bloodbank 
donors The gametocyte carriers were recruited at a dispensary in Yaounde, Cameroon 
TABLE 1, Comparison of activity in the Pfs230 (C230-ELISA) and Pfs48/45 (C45-
ELISA, combined results with 32F3 and 32F1 competition) competition ELISA and 
transmission reduction activity (TBA) in 46 sera of gametocyte carriers trom Cameroon 
C230-ELISA 
C45-ELISA 
positive 
negative 
positive 
negative 
;>85% (n= 
5 
14 
11 
8 
= 19) 
TBA 
<85% (n=27) 
1 
26 
2 
25 
Total 
6 
40 
13 
33 
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Six (13%) out of 46 gametocyte carriers were able to compete HRPO-mAbs in the 
Pfs230 competition ELISA at dilution varying from 1/40 to 1/80. 
Eleven (24%) out of 46 gametocyte carriers were able to compete HRPO-32F3 and 8 
(17%) sera compete the HRPO-32F1 in the Pfs48/45 competition ELISA at dilution 
varying from 1/40 to 1/320 
Nineteen (41 3%) out of 46 gametocyte sera consistently reduced infectivity in the 
Nijmegen bio-assay significantly to less than 15% of the control 
In table 1 the results are presented of the bioassay (TBA) for transmission reduction 
(positive >85%, negative <85%) and competition ELISA for Pfs230 and Pfs48/45 Of 
the 19 transmission blocking sera 5 (26%) were positive in the C230-ELISA and 11 (58%) 
in the C45-ELISA (32F3 and/or 32F1 epitope) The Pfs230 test was positive in 6 of the 
46 sera, one of these had a TBA score of 73% Two of the 13 positive sera in the 
Pfs48/45 test had oocyst counts which did not meet the 85% reduction standard There is 
a positive correlation (for C45-ELISA X2=14 02, P<0 001, for C230-ELISA X2=5 03, 
P<0 04) between TBA and C45/C230-ELISA, which means if TBA > 85% more 
positives in the C45/C230-ELISA were found In table 2, the results of C230-ELISA and 
C45-ELISA are compared of the sera with transmission reduction >85% All 5 sera, 
positive in the C230-ELISA was also positive in the C45-ELISA Of the 11 sera, positive 
in the C45-ELISA, 6 were negative in the C230 ELISA 
TABLE II, Results ot Pfs48/45 (C45-ELISA) and Pfs230 (C230-ELISA) 
competition ELISA's from 19 sera with high transmission reduction 
C45-ELISA positive 
negative 
Total 
positive 
5 
0 
5 
C230-ELISA 
negative 
6 
8 
14 
Total 
11 
8 
19 
In this selection of sera from gametocyte carriers from Cameroon, the Pfs230 specific 
ELISA's seems to add little or no effect to the transmission-reduction predictive value of 
the competition ELISA with the Pfs48/45 blocking epitope as target antigen 
The use of a capturing antibody for the Pfs230 assay is optional as both mAbs react 
also with the antigen directly coated to the microtiter plate In the one-site ELISA, the 5 
Pfs230 specific mAbs, labelled with HRPO, were added together with serial dilutions of 
sera in competition for the specific epitope No differentiation in antibody responses to the 
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Pfs230 epitopes was found, sera positive in one test reacted also with the other epitopes of 
Pfs230 This is in contrast with the results of our epitope specific Pfs48/45 competition 
test (C45 ELISA with 32F3 or 32F1 mAb) 
The combined competition ELISA's predict about 50% of the transmission reductions 
higher than 85% Five sera with 100% blockade were absolutely negative in the ELISA's, 
although the blockade was IgG related 
These results might indicate that other Pfs230 epitopes or other Ρ falciparum antigens 
are involved in inducing the production of transmission-reducing antibodies Moreover, 
transmission-reduction is probably a relatively short lived phenomenon that mainly 
depends on the temporary presence of gametocytes The incidence of reduction that is 
prominently present in gametocyte carriers is now being studied in a longitudinal way 
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ABSTRACT 
Monoclonal antibodies (mAbs) 32F1 and 32F3 react with two independent epitopes of 
a protein doublet with molecular weights 48 and 45 kDa expressed on the surface of 
Ρ falciparum (Pfs48/45) macrogametes and zygotes of which only 32F3 blocks transmissi 
on These mAbs were used to develop a Pfs48/45 specific competition ELISA using 32F1 
to capture antigen and labelled 32F3 for quantification and analysis of the contribution to 
transmission-blocking (ТВ) activity of antibodies in human serum 
A comparison analysis was used to determine agreement of competition ELISA titers 
and ТВ-activity as observed in the bioassay in three groups of serum samples 37 
European travellers with previous exposure to malaria, 56 gametocyte carriers and 66 
school children from a malaria endemic area in Cameroon The index of agreement К 
between outcomes of the ELISA and ТВ assay in gametocyte carriers and in travellers was 
fair/moderate, in school children the agreement was not beyond chance The combined 
analysis of all sera showed a significant and fair/moderate agreement between the results 
of the competition ELISA and the ТВ assay with a relative specificity of 94% and a 
relative sensitivity of 44% This study shows that a positive C48/45-ELISA is indicative 
for ТВ-activity in the mosquito-assay, while a negative result does not exclude ТВ 
activity 
INTRODUCTION 
Gametocytes of Ρ falciparum synthesize 230 kDa and 48/45 kDa molecules which 
remain exposed on the surface of macrogametes and zygotes [1,2,3] Several mAbs 
directed against these molecules block transmission of the parasite to the mosquito vector 
One of the targets of TB-mAbs is the 48/45 kDa glycoprotein doublet (Pfs48/45) Two 
independent, non repetitive epitopes of this protein react respectively with mAbs designa­
ted 32F1 and 32F3 The presence of 32F3 in a mosquito blood meal blocks transmission 
of the NF54 isolate of Ρ falciparum while 32F1 does not [4] The conventional assay 
measuring transmission-reduction in mosquitoes using a feeder system as described by 
Vermeulen and others [1] is costly, labour intensive and thus limits the number of sera 
that can be tested Development of a serologic test predicting ТВ activity would greatly 
simplify epidemiological studies A positive correlation between antibody reactivity to 
Pfs230 and ТВ-activity has been found using immunoprecipitation to quantify the antibody 
response Such a relation was not found for antibody reactivity to Pfs48/45 [5] 
This paper describes the development of a two-site competition ELISA based on the 
32F3 epitope This competition ELISA was used to analyse several sets of field sera In 
addition, the ТВ-activity of these field sera was determined using the feeder assay | 1 | and 
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the results obtained compared with those of the competition ELISA using a statistical 
analysis for comparison of methods [6,7] 
MATERIALS AND METHODS 
Parasites and Pfs48/45 extract 
Mature gametocytes of Ρ falciparum (isolate NF54) were produced in an automated 
large-scale culture system as described by Ponnudurai and others [8] Gametogenesis was 
induced by incubating the mature gametocytes in fetal calf serum (FCS) at room tempera­
ture for 30 minutes Macrogametes and zygotes were purified as described by Vermeulen 
and others [1] Pelleted parasites were stored at -70°C until use Pfs48/45 for use in 
sandwich competition ELISA experiments, was extracted in 25 mM Tris HCl (pH 8 0), 
0 5% Nonidet P40 (NP40), 1 mM phenylmethylsulphonyl fluoride and 1 μg/ml each of 
DNase and RNase Insoluble debris was pelleted by centrifugation (16,000 g, 5 min at 
RT) and the soluble protein extract was stored at -70°C The presence and quantity of 
Pfs48/45 in the extract was determined in a sandwich ELISA using labelled-32F3 and 
32F1 
Transmission-blocking assay 
A bioassay with membrane feeders to feed mosquitoes was used to determine TB-
activity [1,9,10] Briefly, while keeping the temperature at 37°C, fourteen day cultures, 
containing fertile gametocytes were mixed with prewarmed uninfected red blood cells and 
samples of human sera or mAbs, introduced in prewarmed feeders and fed to A gambiae 
mosquitoes All samples were tested in two experiments in the presence of complement 
The minimal obtainable dilution of the sera was threefold and the IgG preparations of 
blocking sera were retested using a tenfold dilution with the malaria negative control 
serum Fully engorged mosquitoes were separated and held at 26°C Seven days later 20 
mosquitoes per feeder were dissected and the number of oocysts on the stomach wall was 
counted and William's mean (adjusted geometric mean) oocysts number was calculated 
[11] An experiment was deemed to have succeeded when at least 90% of the mosquitoes 
examined carried oocysts in each of three controls The adjusted geometric mean was used 
to determine the reduction activity (R) according to the equation 
Τ - Τ 
R = — χ 100% 
Where Τ, is the geometric mean for the test feeder and T
c
 is the mean of the three 
controls 
If the transmission reduction value of a given serum was lower than 85% a considerable 
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variation could be observed among independent repeated tests Values over 85% were 
consistent in subsequent experiments and only those were considered as positive in the 
ТВ-assay in this paper 
Reduction of transmission in the feeder assay was confirmed using the immunoglobulin 
fraction of these sera 
Antibodies 
Serum samples were obtained from the following groups 
1) 56 gametocyte carriers (aged between 6-36 years) recruited at a dispensary in 
Yaounde, Cameroon [12], 
2) 37 European travellers (aged between 6-70 years) to malarious regions with antibody 
titers to Ρfieldi asexual parasites determined by the indirect immunofluorescence 
assay (IFA), 
3) 66 school children (aged between 8-12 years) from Edea, Cameroon [13] 
A panel of individual and pooled sera from Dutch bloodbank donors, without previous 
malaria experience, was used as negative controls 
As a positive control in every test the serum from one individual who had worked in a 
malaria area in Tanzania for more than 30 years was included 
Complement Freshly obtained AB blood from Dutch bloodbank donors, without 
previous malaria experience, was allowed to clot at room temperature for 1 hour Aliquots 
of the resulting serum were stored at - 70°C until used 
Sandwich Competition ELISA (C48/45-ELISA) 
Biotin labelling of mAb 32F3 was performed according to the procedure described by 
Verhave and others [14], and horseradish peroxidase (HRPO) labelling following the 
periodate method using an input HRPO/IgG molar ratio of four was carried out according 
to the method described by Wilson and Nakane [15] The labelled mAbs were dialyzed 
against phosphate buffered saline (PBS), supplemented with thimerosal (0 01%) and FCS 
(1%) and stored at 4°C 
The basic procedure was that of the two-site ELISA All incubations were carried out 
at room temperature To capture Pfs48/45, wells of microtiter plates (Hycult) were coated 
with 50 μ\ of a 10 μg/ml concentration of 32F1 in PBS for 45 min Plates were washed 
three times with PBS Wells were saturated with 150 μ\ of 2% BSA in PBS for 30 mm 
After three washes with PBS, the wells were incubated for 2 hrs with 50 μΐ of the NP40 
parasite extract (see above) containing the equivalent of 200,000 gametes/zygotes diluted 
in TNP (25 mM Tris-HCI pH 8 0, 150 mM NaCI, 0 1% NP40) Following three washes 
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with PBS, wells were incubated with 30 μΐ test serum sample and 30 μ\ labelled-32F3 for 
2 hrs. For the biotin label, an additional incubation step with streptavidin-biotinylated 
peroxidase complex (Amersham; 1:3,000 diluted in PBS containing 0.05% Tween-20) 
preceded the incubation with substrate solution. For both labels the wells were washed 
four times with PBS and incubated for 20 minutes with 60 μΐ TMB (0.25 mM 3,3',5,5'-
tetra-methyl-benzidine, 0.7 mM H202 in 0.1 M sodium-acetate pH 5.5) substrate solution. 
The peroxidase-substrate reaction was stopped by adding 60 μΐ 2 M H2S04 and the optical 
density (OD) was determined in an ELISA-reader at 450 nm (Titertek Multiskan MCC/-
340). 
For optimal immunoreaction labelled-mAbs and antigen were tested in a chequerboard 
titration. From this antigen-antibody titration concentrations of labelled mAb and antigen 
were chosen resulting in >60% of maximal OD of labelled mAb and an OD reading of 
>1.0. 
Competition is detected as a reduction in the OD reading obtained with the mAb alone 
in the presence of a negative control serum. The true endpoint is defined as the dilution 
(titer) at which the positive sample reaches the OD value of the negative control. Sera 
with true endpoint > 1/20 are considered positive. 
Comparison of the ТВ-assay and competition ELISA 
The results of the competition ELISA were compared with those obtained by the TB-
assay and analysed by a statistical test on agreement using kappa as the index of observed 
agreement [6,7]. The index kappa (K) is calculated from the observed and expected (by 
chance) frequencies on the diagonal of the 2x2 table of ТВ-activity outcomes in the 
bioassay (>85%, <85%) and results of the competition ELISA (positive, negative). 
The index is given by К = (P„ - P
c
)/(1 - Ρ J 
η 
where 1) P0 = observed proportional agreement, i.e., P0 = Σ ƒ„ / η 
ι = 1 
were ƒ„ is the number of agreement for category ι (i= 1,2) 
and η is the number of examined sera, 
2 
2) P
c
 = expected proportional agreement by chance, i.e, P
e
 = Σ r,c, / n2 
1 = 1 
were r, and c, are the row and column totals for the іш category (i= 1,2). 
Pod-Po) 
The approximate standard error of К is SE(K) =, 
\ n(l-P
e
)2 
and the approximate 95% confidence interval is given by К + 1.96 SE(K). 
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TABLE 1 Guideline for the interpretation 
of the index of agreement kappa (K). 
Value of К Strength of agreement 
¿0 20 poor 
0 21-040 fair 
0 41 - 0 60 moderate 
0 61 - 0 80 good 
0 81 1 00 very good 
The index of agreement К has a maximum 1.00 when agreement is perfect, values of 
zero or below indicate no agreement better than chance. While no absolute interpretation 
is possible the guideline proposed by Altman [6] was used to determine the strength of 
agreement (Table 1) 
RESULTS 
Testing of the labels and competition with serum antibodies 
The optimal concentration of labelled-mAb and the optimal amount of antigen coated 
per well as determined in the chequerboard titrations, were respectively 2 μg/ml for the 
biotin label and 200,000 macrogamete/zygote-equivalents / well, and 1 μg/ml for the 
HRPO-label and 100,000 macrogamete/zygote-equivalents / well. The maximal OD of the 
HRPO-32F3 label was higher than that of the biotin-32F3 label using the same concentra­
tion of antigen. Competition of labelled mAb with increasing concentrations of nonlabel-
led mAb is depicted in Figure 1. The 50% competition values of the corresponding 
unlabelled mAb were 0 25 ^g/ml for the I 0 ¿ig/ml HRPO-label and 1.3 μg/ml for the 2 0 
μg/ml biotin-label. In addition, it appeared that the biotin-32F3 competition ELISA was 
positive with 7 out of 19 sera having positive ТВ-activity as observed in the bioassay, 
whereas the HRPO-32F3 competition was positive for 9 out of 19 sera Due to the limited 
sensitivity of the biotin-32F3 competition ELISA human sera could not be diluted more 
than 1 in 10 preventing a complete titration of the sera The mAb 32F1 (anti Pfs48/45) 
and mAbs against 25 kDa and 230 kDa antigens were negative in the competition test up 
to a concentration of 330 μ§/πιΙ 
Figure 2 shows examples of the competition of serial dilutions of sera with the 
HRPO-32F3 label Data of the negative serum are the mean of 14 individual sera tested 
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% competition 
100 
0 1 1 
pg of unlabeled 32F3 / ml 
Figure I Two-site competition ELISA 32F1 was used to capture Pfs48/45 from a 
NP-40 extract ( + ) HRPO-32F3 (1 /ig/ml with 100,000 macrogamete/zygote-equiva-
lents/well) and ( д ) biotin-32F3 (2 μg/ml with 200,000 macrogamete/ zygote-equiva 
lents/well) was used as label in competition with serial dilutions of nonlabelled 32F3 
on 3 separate occasions Calculation of the overall intra-assay variation resulted in an 
average deviation of the mean OD of 0 08 (10%) The overall inter-assay variation 
resulted in an average deviation of the mean OD of 0 11 (14%) The titration values of 3 
sera that were positive in the competition ELISA are depicted using the overall mean of 
duplicate determinations of two independent tests 
Control experiments with 14 sera from Dutch bloodbank donors exhibited a nonspeci­
fic reduction up to a maximum of 15% of the OD of the HRPO-32F3 label compared to 
reactions without competing serum antibodies This nonspecific reduction was not seen 
with IgG preparations of these sera Nevertheless, the competition titer found for sera and 
their corresponding IgG preparations were the same 
Comparison of competition ELISA and ТВ-assay in several groups of sera 
Table 2 shows the results of the competition ELISA and the ТВ assay for the sera of 
gametocyte carriers, travellers and school children Using the HRPO-32F3 label 17 (30%) 
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Figure 2. Inhibition ot binding of HRPO-32F3 in the presence of serial dilutions of 
human serum. Negative serum (o); each data point represents the mean ± SD of tour-
teen determinations performed on three different days Three sera positive in the 
competition-ELISA ( Α , Δ , + ) , each data point represents the mean of duplicate 
determinations performed on two days. For concentrations of antigen and HRPO-32F3 
see legend to Figure 1. 
out of 56 of the gametocyte carriers exhibited significant competition in the ELISA. These 
results were compared with the corresponding ТВ-activity observed in the bioassay. 
By shifting the ТВ-assay cut-off point in the gametocyte carrier group in the range 
10%-90%, it appeared that the maximum degree of agreement between ТВ-assay and 
C48/45-ELISA was at the 85% reduction point. Furthermore it appeared that the agree­
ment between ТВ-assay and C48/45-ELISA was not above chance if the cut-off point of 
the ТВ-assay was set at a reduction lower than 70% (95% confidence interval of К 
included the value 0). At the 85% reduction point the index К assumed the value 0.40, 
indicating fair/moderate agreement between the outcomes of competition ELISA and TB-
assay (Table 3). Four of the 17 positive sera from gametocyte carriers in the C48/45-
ELISA test had oocyst counts that did not meet the 85% reduction standard. Of the 25 
sera that were positive in the TB-assay, 13 had antibodies competing with the HRPO-
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TABLE 2 Activity in the Pfs48/45 competition ELISA (C48/45-ELISA) and in the 
transmission-blocking assay (ТВ-assay) in sera of gametocyte carriers, travellers and 
school children 
C48/45-ELISA test results 
56 gametocyte carriers 37 travellers 66 school children 
ТВ-assay positive negative positive negative positive negative 
> 85% 
< 85% 
13 
4 
12 
27 
10 
18 
8 
54 
17 39 28 62 
TABLE 3 Comparison ot activity by index of agreement К in the Pfs48/45 competition 
ELISA (C48/45-ELISA) and the transmission-blocking assay in sera of gametocyte earners, 
travellers and school children 
Index of agreement К 
group 
56 gametocyte carriers 
37 travellers 
66 school children 
К 
0 40 
0 47 
0 22 
95% conf. interval 
0 15-0 65 
0 19-0 75 
-0 23 0 67 
Strength 
fair/moderate 
fair/moderate 
not beyond chance 
32F3, indicating a relative sensitivity of 52% Of 31 sera considered negative by ТВ assay, 27 
were also found negative by C48/45-EL1SA, showing a relative specificity ot 87% ot the 
competition ELISA 
Nine (24%) out of 37 sera of the group of travellers exhibited significant activity in the 
ELISA Nine (47%) out of 19 sera, positive in the ТВ assay had antibodies competing with the 
HRPO-32F3 All sera (18) considered negative by the ТВ assay were also negative by C48/45 
ELISA The index ot agreement К between ТВ-assay and C48/45-EL1SA tor the group of 
travellers, assumed a value of 0 47, indicating moderate agreement (Table 3) 
Four (6%) out ot 66 sera ot school children showed significant competition in the ELISA 
Only 2 (20%) out ot 10 sera, positive in the ТВ-assay, were positive in the competition ELISA 
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The relative specificity was 96% (54 out of 56) The index of agreement К between the results 
of the C48/45-ELISA and the ТВ-assay was low with a wide confidence interval (K = 0 22, 
95% confidence interval -0 23, 0 67) Since the confidence interval contains zero, chance can 
explain the observed level of agreement 
A summary of the data of the 3 groups combined is given in Table 4 The index of agree­
ment К between the results of the C48/45-ELISA and the ТВ-assay is К = 0 44, with 95% 
confidence interval 0 28, 0 60 indicating fair/moderate agreement (Table 1) The ELISA 
outcomes show a relative specificity ot 94% (99 of 105) and a relative sensitivity of 44% (24 of 
54) 
TABLE 4 Comparison' of activity in the transmission-blocking assay (ТВ-assay) and in 
the Pfs48/45 competition ELISA (C48/45-ELISA) in all field sera combined 
C48/45-ELISA test results 
ТВ-assay positive negative Total 
S; 85% 24 30 54 
< 85% 6 99 105 
Total 30 129 159 
' Relative specificity = 94% (99 of 105) Relative sensitivity 44% (24 at 54), 
Index ot agreement К = 0 44 
DISCUSSION 
A mAb based competition ELISA was developed to study the natural antibody reactivity to 
Pfs48/45 in field sera in comparison to ТВ-activity as observed in a bioassay The 32F3 labelled 
mAb was used in this competition ELISA because of its blocking activity in the TB-assay 
Competition of antibodies in field sera with labelled 32R for binding to Pfs48/45 might therefore 
be relevant for ТВ-activity Transmission blockade has not been found in serum ot rabbits 
immunized with recombinant Pfs48/45 (unpublished data) Therefor Pfs48/45 extract trom 
parasites was used as antigen in the competition ELISA 
The concentration ot non labelled antibody necessary to reduce binding of the labelled mAb 
in the competition ELISA was lower tor HRPO-labelled 32F3 than lor biotin labelled 42F3 This 
was supported by the observation that in the competition ELISA with HRPO 32F3 as label 9 out ot 
19 blocking field sera were positive in contrast to 7 out of 19 when biotin 32ГЗ was used 
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Therefore, HRPO-labelled 32F3 was used in the competition ELISA's of subsequent experiments. 
ТВ-activity was found in a high proportion of sera from gametocyte carriers and travellers to 
malarious regions. In the group of travellers, all sera positive in the C48/45-ELISA blocked trans­
mission, but 10 out of 19 blockers were negative in the C48/45-ELISA. Pfs48/45 has several, 
surface exposed domains recognised by mAbs [16,17]. Since only one domain potentially involved 
in blocking activity could be analysed in this study, reactivity to other domains might explain why 
10 out of 19 blockers were negative in the C48/45-ELISA. Since sera from people living in 
endemic areas react to all epitopes tested on the Pfs230 (unpublished data), several alternative 
explanations may be considered. It may be that blocking reactivity is targeted to other than the 
Pfs48/45 molecule, or blocking does not only depend on antibody, but may also be caused by 
nonspecific factors as observed in P.vivax and P.falciparum infections [18]. In our analyses it 
appeared, however, that IgG tractions of sera with ТВ-activity blocked transmission too. Although 
this does not exclude the presence of nonspecific ТВ-activity, specific activity can explain the 
results. It is also possible that the C48/45-ELISA is less sensitive than the TB-assay. 
The results of the gametocyte carriers and school children gave an additional problem 
because respectively 4 out ot 17 and 2 out of 4 sera positive in the C48/45-ELISA were in the 
non-blocking group (<85%) It should be noted that the category R < 85% in the ТВ-assay does 
not necessarily mean that there is no transmission-reduction. It only shows that repeated experi­
ments with sera from this group exhibited considerable variation of the transmission-reduction 
value, making it impossible to subdivide the group with R value's < 85% in different subclasses. 
A statistical test for comparison of proportions or association is not considered appropriate 
tor the comparison of the outcomes of ТВ-assay and C48/45-ELISA Besides sensitivity and 
specificity, measure of agreement is required rather than association. The kappa (K) measure, 
which measures the amount of agreement beyond chance seems to fit our purpose In 2 of 3 
groups of sera agreement was significant, (fair/moderate for gametocyte carriers and travellers) 
and only in the group of school children agreement between the outcomes of the two methods 
could be explained by chance Nevertheless, overall a tair/moderate agreement was found. In 
addition, the C48/45-ELISA exhibited reasonable levels ot sensitivity (>44%) and specificity (> 
94%). 
Analyses of a panel of sera from Papua New Guinea using immunoprecipitation ot Pfs48/45 
and competition of these sera with mAb IIC5B10 did not reveal a correlation between TB-activity 
and serologic reactivity to Pts48/45 [5] It may be considered that the ТВ-activity of IIC5B10 is 
comparatively low compared to 32F3 [19]. 
On the other hand, the analyses ot the Papua New Guinea sera revealed a correlation between 
serologic reactivity to Pfs230 and not Pfs48/45 and TB-activity [5]. Our competition is specific 
(94%) but only positive in 44% of the sera with ТВ-activity. This leaves the possibility that the 
competition ELISA is insensitive or that ТВ-activity in these sera is directed to other sexual stage 
molecules e g Pfs230 as observed by Graves and others [5] 
In summary, the TB-bioassay is a costly, comparatively labour intensive and time consuming 
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test A Pfs48/45 epitope specific competition ELISA has a significant predictive value to the ΤΒ-
activity being limited by the fact that only 44% of all ТВ-sera are positive in the competition 
ELISA This indicate the need to increase sensitivity of the test and/or to define additional 
transmission-blocking targets 
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ABSTRACT 
Pfs48/45, a sexual stage parasite protein doublet of Ρ falciparum, is a target of antibo­
dies which inhibit the development of the parasite in the mosquito Twenty eight (54%) o-
ut of 52 sera of gametocyte carriers from Cameroon reduced infectivity in the mosquito 
membrane feeding bioassay to less then 20% of the controls These 52 sera were analysed 
by competition ELISAs for the presence of antibodies capable of competing the binding of 
six mAbs directed against five different epitopes on Pfs48/45 The percentage of these 52 
Cameroon sera that competed with one of the mAbs ranged from 13% (epitope I) to 33% 
(Epitope He) Comparison of activity in the transmission-blocking (ТВ) assay (>80%) 
and in the Pfs48/45 competition ELISA show a relative specificity of 100% (24 of 24) and 
a relative sensitivity of 75% (21 of 28) Non blocking sera showed no competition with 
any of the mAbs These mAbs were further used to study the diversity of epitopes among 
isolates of Ρ falciparum using a two-site ELISA MAbs against epitope I, III and V 
reacted with four different isolates whereas epitope II could be subdivided into three 
epitopes None of the isolates reacted with mAb 3G12 (epitope IV) Using these four 
different isolates, the competition ELISA titer varies from 1/20 to 1/80 and no significant 
differences are found between the isolates except for epitope II where only three out of 11 
positives for epitope Ha were also positive for epitiope He 
INTRODUCTION 
Gametocytes of Ρ falciparum synthesize molecules of apparent M
r
 on SDS-PAGE of 
230 kDa and 48/45 kDa (Pfs230 and Pfs48/45) which are expressed on the surface of 
macrogametes and zygotes [12,23] A number of monoclonal antibodies (mAbs) against 
the Pfs48/45 protein doublet are able to block transmission of the parasites to the mosqui­
to vector |4,17,20,23] 
Three epitopes of Pfs48/45 were identified by Carter et al [2,3] MAb to epitope 1 
(mAb 3E12) blocks transmission effectively but mAbs to epitopes II (mAb IA3 B8) and III 
(mAb ПС5 BIO) were ineffective on their own but able to reduce transmission when used 
in combination Another epitope (IV) was defined by its reactivity with a non blocking 
mAb 3G12, that bound Pfs48/45 only under reduced conditions on a Western immunoblot 
[4] Diversity in epitope II was found in two Libenan isolates when gametocytes of 15 
different isolates from a variety of endemic areas were tested for binding of mAbs to 
Pfs48/45 by indirect immunofluorescence and immunoprecipitation |6] Epitope II is 
subdivided into epitopes a, b and с of which a and с represent the genetic variants |4 | 
Similar findings were obtained by Foo et al |5] in a series of 33 Ρ falciparum isolates 
from Malaysia, variation exists in epitope Ha and He, while epitope I, lib. III and IV are 
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markedly conserved Using the PCR technique nucleotide and amino acid sequence 
differences were observed between the Pfs48/45 genes of 8 different strains of Ρ falcipa­
rum by Koeken et al [11] The results showed that the amino acid residue at position 254 
in Pfs48/45 determined whether this antigen will bind to a mAb specific for epitope Ila or 
epitope He 
The availability of a larger panel of mAbs permitted the identification of five indepen­
dent antibody binding sites on Pfs48/45 [20] and ТВ-activity appeared no longer to be 
restricted to epitope I recognition ι e mAbs against epitope II, III and V were all able to 
block transmission Furthermore, blocking was not associated with particular epitopes and 
blocking and non-blocking mAbs competed for the same binding site 
Anti-Pfs48/45 antibodies are widely present in sera from individuals living in malaria 
endemic areas [5,6,18] Since Pfs48/45 is a target protein for TB antibodies, a study was 
carried out to analyse the possible association between ami Pfs48/45 antibodies and the 
capacity to reduce transmission in the membrane feeding bioassay in sera from naturally 
infected individuals This classical test is a laborious and time consuming assay that 
cannot easily be transferred to endemic areas and used for epidemiological studies There­
for, an easy field test is required to study the possible impact of ТВ-immunity for malaria 
The presence of anti Pfs48/45 antibodies in sera was previously determined by a competi 
lion ELISA using an anti Pfs48/45 mAb recognizing epitope I (mAb 32F3, [18] In that 
study ТВ activity was predicted with a specificity of 96% and a sensitivity of 44% in sera 
of gametocyte carriers from Cameroon Here we further extend these findings by using a 
panel of 6 different mAbs directed against epitope I, II, III and V In addition, the specifi­
city of epitope reactivity was studied in 4 isolates 
MATERIALS AND METHODS 
Parasites 
Mature gametocytes of Ρ falciparum (isolate NF54 (Amsterdam, airport strain), 7G8 
(Brazil, Burkot 1984), PNG94 (Papua New Guinea, Graves 1988a), TT1 (Cameroon 
strain)) were produced in an automated static culture system as described by Ponnudurai et 
al [14] Gametocytes were isolated as previously described [19] The purified gametocy­
tes were stored at -70°C until used 
Monoclonal antibodies and sera 
MAbs 32F1 and 32F3 have been described by Vermeulen et al [23] MAbs 3E12 (epitope 
I), IA3 B8 (epitope Ha), IIC5 BIO (epitope III) and 3G12 (epitope IV) were a kind gift 
of Dr R Carter MAbs 82D6 AIO (epitope He) and 84A2 A4 (epitope V) have been 
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described by Targett et al [20] 
Field sera 52 sera were collected from gametocyte carriers (aged between 6-36 years) 
recruited at a dispensary in Yaounde, Cameroon [22] 
Sp3 and Sp5 are sera collected from a Ρ falciparum infected Dutch expatriate respectively 
3 and 5 weeks after return from Cameroon who worked there for more than 30 years 
The sera Sp3 and Sp5 were collected while the patient was a Ρ falciparum gametocyte 
carrier 
Serum (St) is from a Dutch expatriate who worked in an endemic malaria area in Tanzania 
for more than 30 years 
Negative control (N56) A pooled serum sample obtained from Dutch bloodbank donor 
volunteers, without any history of malaria, collected in the absence of a potent infecti­
on 
Transmission-blocking assay 
A modification of the bioassay, using membrane feeders to feed A gambiae mos­
quitoes, was used to determine ТВ-capacity of serum samples [15,16,23] Percentage 
reduction of oocysts was calculated according to the equation R = (TC T,) / Tc χ 100% 
where T
c
 is the geometric mean of oocyst number observed after feeding with three 
control sera and T, is the geometric mean of oocyst number observed after feeding with 
the test serum [19] 
Enzyme-linked immunosorbent assays (ELISAs) 
Pfs48/45 of different isolates was extracted in 25 mM TNP (Tris HCl (pH 8 0), 150 
mM NaCl, 0 5% Nonidet P40 ), 1 mM phenylmethylsulphonyl fluoride and 1 ^g/ml each 
of DNase and RNase Insoluble debris was pelleted by centnfugation (16,000g, five 
minutes at room temperature) and the supernatant was stored at -20°C until use 
Two-site ELISAs and two-site competition ELISAs using gametocytes of different 
isolates and horseradisch peroxidase (HRPO) labelled Protein-Α purified mAbs were 
carried out as previously described [18,19] Briefly, wells of microtiterplates were coated 
with 50 μΙ of anti-Pfs48/45 mAb (10 μg/ml) in PBS for 30 minutes Wells were saturated 
with 150 μΐ of 5% foetal calf serum (FCS) in PBS for 30 min After three washes with 
PBS, the wells were incubated for two hrs with 50 μΙ of the NP40 gametocyte extract, 
containing the equivalent of 150,000 gametocytes diluted in TNP Following three washes 
with PBS, wells were incubated with 50 μΐ HRPO-labelled anti-Pfs48/45 mAb (2 ßglm\) 
for two hours After four washes with PBS, wells were incubated with 60 μΐ TMB (0 25 
mM 3,3',5,5'-tetra-methyl-benzidine, 0 7 mM H,02, 0 1 M sodiumacetate pH 5 5) 
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substrate solution for 20 minutes The enzyme reaction was stopped by adding 60 μ\ 4 N 
H2SO, and the optical density (OD) was determined on an ELISA-reader at 450 nm 
(Titertek Multiskan MCC/340) All incubations were carried out at room temperature. 
For the competition ELISA, Pfs48/45 was captured from a TNP extract in microtiter-
plates as described above. After three washes with PBS, wells were incubated with a 
mixture of 30 μ\ test sample and 30 μ\ HRPO-labelled anti-Pfs48/45 mAb (1 μg/ml) for 2 
hours Competition ELISAs were carried out using serial two-fold dilutions of unlabelled 
anti-Pfs48/45 mAbs (ranging from 0.1 - 10 /xg/ml) or human sera diluted in PBS contai­
ning 0.1% FCS ranging from 1/10 to 1/2560 dilution in competition with one of the 
HRPO-labelled mAbs The plates were washed, incubated with substrate and the absorban-
ce read at 450 nm as above 
For purposes of standardization each ELISA was done with a positive and a negative 
control The competition titer was defined as the dilution of the test serum that resulted in 
the same OD value as the mean +2SD of OD values for 14 non-exposed control sera 
Sera with a dilution titer > 1/20 are considered positive [18]. 
RESULTS 
Immunoreactivity of anti-Pfs48/45 mAbs using two-site ELISAs 
Epitope specificity of the mAbs was determined by competition between labelled and 
unlabelled mAbs in two-site competition ELISAs and determining the binding characte­
ristics to Ρ falciparum isolates which are known to be different in Pfs48/45 phenotype. 
Checkerboard titrations with labelled mAbs and antigen extracts were performed to 
establish optimal conditions for Pfs48/45 detection None of the labelled mAbs bound to 
Pfs48/45 when captured by the corresponding unlabelled mAbs indicating that all epitopes 
are non-repetitive 
Table 1 shows the reactivity of 3 anti-Pfs48/45 mAbs recognizing epitope II with 4 
different geographical isolates. While mAb IA3 B8 reacts exclusively with isolate 7G8, 
mAb 82D6 AIO reacts with all isolates except 7G8. These data confirm previous findings 
by Graves et al 1985 and Foo et al. 1991 showing variation in epitope II between diffe­
rent isolates as detected by ìmmunoprecipitation or immunofluorescence microscopy 
HRPO-labelled mAb 32F3 (epitope I), IIC5.B10 (epitope III) or 84A2.A4 (epitope V) 
reacted with these 4 different isolates No reactions were found in our two-site ELISAs 
using the four isolates as antigen with mAb 3G12 or the HRPO-labelled mAb 3G12 
whereas this mAb reacted positive in the immuno-fluorescence assay using air dried, 
aceton fixed gametocytes of isolate NF54 or 7G8 (data not shown) 
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TABLE 1 Two-site ELISA with HRPO labelled ami-Pfs48/45 mAbs ot the 
different epitopes using antigen from 4 different isolates captured by a mAb 
epitope 
I 
II a 
l ib 
l i e 
III 
IV 
V 
second 
HRPO-mAb 
32F3 
IA3 B8 
32F1 
82D6 AIO 
IIC5 BIO 
3G12 
82D6 AIO 
NF54 
+ 
+ 
+ 
+ 
+ 
Isolate* 
PNG 
+ 
-
+ 
+ 
+ 
-
+ 
7G8 
+ 
+ 
+ 
-
+ 
-
+ 
TT1 
+ 
-
+ 
+ 
+ 
-
+ 
1
 Isolate NF54 (Amsterdam, airport stram) 7G8 (Brazil), PNG (Papua New 
Guinea) and TT1 (Cameroon), (+) positive reaction, ( ) no reaction 
ТВ-activity and Pfs48/45 competition titer of human sera 
The reactivity of mAbs with different isolates including NF54 and a Cameroonian 
isolate as described in table 1 shows comparable reactivity between NF54 and TT1 from 
Cameroon A panel of 52 sera from gametocyte carriers in Yaounde was used to study for 
ТВ-capacity and presence of natural anti-Pfs48/45 antibody reactivity using NF54 as 
isolate (Table 2) Twenty-eight (54%) out of 52 sera of gametocyte carriers from Came 
roon reduced transmission (mean oocyst number) in the bioassay to less than 20% of the 
value observed in malaria negative control sera and 6 of these sera completely blocked 
transmission The proportion of sera competing for a given epitope was 13% (7 sera) for 
epitope I, 21% (11 sera) for epitope lib, 29% (15 sera) for epitope III, 31% (16 sera) for 
epitope V and 33% (17 sera) for epitope He Twenty-one (40%) of the 52 sera were able 
to compete binding to any epitope and were always able to reduce transmission more than 
80% Out of the 28 transmission-reducing sera, 7 (25%) were positive for epitope I, 11 
(39%) for epitope lib, 15 (54%) for epitope III, 16 (57%) for epitope V and 17 (61%) for 
epitope He The combined Pfs48/45 competition ELISAs were positive in 21 (75%) of the 
28 sera with a transmission-reducing activity of more than 80% None of the non-blocking 
sera (24 of 52) exhibited activity in any of the anti Pfs48/45 competition ELISAs Seven 
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TABLE 2 Reactity of 52 sera from Ρ falciparum gametocyte carriers in the 
bioassay for transmission-reducing activity and the competition test for Pfs48/45 
epitopes using NF54 isolate 
Epitope of Pfs48/45* 
Serum 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29-52 
R' 
98 
100 
96 
100 
89 
91 
88 
91 
97 
84 
82 
97 
100 
90 
90 
81 
80 
100 
81 
94 
83 
96 
99 
100 
90 
100 
99 
90 
<80 
I 
160' 
40 
40 
640 
160 
80 
40 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
_ 
lib 
20 
80 
160 
40 
-
-
-
160 
160 
20 
80 
40 
20 
20 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
_ 
He 
40 
80 
80 
80 
40 
40 
-
40 
40 
40 
40 
20 
20 
-
40 
40 
20 
20 
20 
-
-
-
-
-
-
-
-
-
_ 
III 
20 
80 
40 
80 
40 
40 
-
40 
20 
40 
40 
-
-
-
40 
40 
40 
20 
-
20 
-
-
-
_ 
-
-
-
-
_ 
V 
40 
40 
80 
40 
20 
40 
-
80 
40 
40 
40 
20 
-
-
40 
40 
20 
-
20 
-
20 
-
-
-
-
-
_ 
-
_ 
4
 - Competing antibodies for epitope I, lib, lie. III and V were respectively mAb 
32F3, 32F1, 82D6 AIO, ПС5 BIO and 84A2 A4, ' = percentage reduction in TB-
assay, * = Reciprocal serum titer, (-) = Titer <20 
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out of 28 ТВ-sera did not compete the mAbs of the different epitopes used in this study. 
The negative control serum does not reduce the OD reading of the labelled mAbs for 
any of the Pfs48/45 epitopes. The activity of the ТВ-assay (positive if >80%, negative if 
<80%) was compared to the results of the competition ELISA for Pfs48/45 (positive if 
titer > 20, negative if <20) in a two by two table. The results of these data showed a 
relative specificity i.e. proportion negative in both tests of 100% (24 out of 24) and a 
relative sensitivity, i.e. proportion blockers positive in the competition ELISA of 75% (21 
out of 28). 
TABLE 3. Reciprocal competition titer for different Pfs48/45 epitopes in human sera 
with anti-Pfs48/45 mAbs. 
Epitope of Prs48/45' 
Serum I IIa IIb He III V 
St2 320' 320 320 320 320 320 
Sp3 640 640 - 80 2560 80 
Sp5 2560 1280 - 80 2560 80 
N56 - - - - - -
St2 = Positive control serum; Sp = Serum samples from a Dutch expatriate collected in 
week 3 (Sp3) and 5 (Sp5) after returning from Cameroon; N56 = A pool from Dutch blood 
donors with no history of malaria; " = Reciprocal serum titer; (-) = Titer < 20; * = For 
all competition test NF54 isolate was used execpt for epitope IIa where 7G8 isolate was 
used as source of Pfs48/45. Competing antibodies for epitope I, IIa, lib, He, III and V 
were respectively mAb 32F3, IA3.B8, 32F1, 82D6.A10, IIC5.B10 and 84A2 A4. 
Antibody reactivity with Pfs48/45 epitopes of different isolates. 
Table 3 shows the results of two-site competition ELISAs with serial dilutions of 
malaria negative serum (N56) and sera from 2 Dutch expatriates (St2, Sp3 and Sp5). Sera 
from these Dutch expatriates completely block transmission (data not shown). Serum St2 
competes with all HRPO-labelled mAbs for all epitopes in a dilution of 1/320. Sera from 
donor Sp (Sp3, Sp5), with a gametocyte positive thick smear 3 and 5 weeks after retur­
ning from Cameroon, competes with all epitopes except epitope lib. Reactivity of the Sp 
samples against epitopes He and V was much lower than reactivity to epitopes I, IIa and 
III. In addition, reactivity against Pfs48/45 was higher in the expatriate sera, relative to 
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the sera of the gametocyte carriers (Table 2) Sp3, Sp5 (Table 3), and also ten out of 21 
sera from gametocyte carriers, positive for at least one of the Pfs48/45 epitopes (Table 2), 
did not show any competition with mAb 32F1 recognizing epitope lib Only for epitope I 
we see an increase in titer for donor Sp In contrast to the mAb reactivity (Table 1) a 
positive reaction was found for both epitopes Ha and He with sera from these 2 Dutch 
expatriates 
TABLE 4 Pfs48/45 reactivity against different isolates in sera from Ρ falciparum 
gametocyte carriers using the epitope specific competition ELISAs 
Pfs48/45 reactivity (n=20) 
positive with at least one epitope 
epitope II* 
epitope III* 
epitope V* 
NF54 
12 
IIa 
9 
11 
TT1 
9 
8a 
7 
9 
Isolate 
PNG94 
12 
10a 
9 
10 
7G8 
10e 
з
ь 
8" 
8 
* = epitope Ha as defined by mAb IA3 B8, He by mAb 82D6 AIO, epitope III by mAb 
IIC5 BIO, epitope V by mAb 84A2 A4, ' = positive for epitope Ile, k - positive for 
epitope Ha, c = 19 sera tested, d = 18 sera tested 
With a selection of 20 out of 52 sera from gametocyte carriers competition ELISAs 
against different epitopes of Pfs48/45 were carried out using four Ρ falciparum isolates 
The results are described in Table 4 Eight of the 20 sera were negative in the competition 
ELISAs with NF54 as well as with isolates TT1, PNG94 and 7G8 The 12 competition 
positive with NF54 were also tested with the 3 other isolates All sera recognized the 
PNG isolate, but three out of 12 sera did not compete Pfs48/45 mAbs binding to TT1, one 
out of 11 did not show positive competition with 7G8 Serum titers varied between 1/20 
and 1/80 showing no major difference between the isolates In 3 sera (4, 8 and 15 in 
Table 2) we find competition for both epitope He and IIa 
DISCUSSION 
Antibody responses to gametocyte antigens occur in individuals exposed to Ρ falcipa­
rum [7,8,9,10,18,19,21] including those who had experienced only primary infections [13] 
Competition ELISAs using six mAbs, recognizing different epitopes of Pfs48/45 were 
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carried out to determine the binding specificities of the naturally acquired antibodies to 
Pfs48/45 Our results confirm the reactivity of different mAbs with the epitopes described 
by Carter et al [2,4] and Targett et al [20] No reaction was found in our two-site ELI­
SAS with mAb 3G12. Enhancement of binding of HRPO-labelled mAbs in the presence of 
sera to the captured antigen was never seen in these competition ELISAs (data not shown) 
in contrast to findings by Targett et al. [21] or Graves et al [8,10] 
In a panel of sera from gametocyte carriers, 28 sera exhibited more than 80% transmis­
sion-reducing activity. Twenty-one of these gametocyte carriers were positive in anyone of 
a Pfs48/45 competition ELISA but individual sera might have only one specificity or any 
combination of two or more specificities. It is interesting to note that considerable variation 
was seen in the antibody responses to each of the five epitopes on the Pfs48/45 molecule, 
all of which are associated with transmission-reducing activity The combined Pfs48/45 
competition ELISAs predict 75% (21 out of 28 sera) of the observed transmission-reducing 
activity that is higher than 80% No positive Pfs48/45 competition reaction was observed 
in sera that reduced transmission in the bioassay less than 80%. 
A similar competition ELISA was used by Graves et al. [8,9,10] and Ong et al [13] 
with mAbs including 3G12 against 3 different epitopes and X10 or XP12 as source of 
Pfs48/45 Graves el al. [10] showed a significant association between lack of infectivity of 
Ρ falciparum gametocyte carriers and recognition of epitope lia on Pfs48/45 by antibodies 
in their sera In another study, mAb IIC5 BIO was used to compete with a panel of Papua 
New Guinea sera The results of the competition ELISA did not correlate with TB-activity 
observed in these field sera [7,8] We have previously described a correlation between 
suppression of infectivity of in vitro cultured gametocytes to mosquitoes in a bioassay and 
reactivity in an anti-Pfs48/45 two-site competition ELISA by immune sera [18]. In that 
study Pfs48/45 was captured from a NF54 parasite extract by mAb 32F1 (epitope 2b) and 
the sera competed with mAb 32F3 (epitope 1). The results showed that the competition 
ELISA for one epitope had a relative sensitivity of 44% and a relative specificity of 94% 
The data described in this paper exhibit a 100% specificity and an overall relative sensitivi­
ty of 75%. It remains to be determined why 25% of the sera with ТВ-activity are negative 
in any of the competition ELISAs In addition, three sera bound to NF54 derived Pfs48/45 
did not recognize TT1 parasites, whereas another serum did not recognize 7G8 parasites 
Possible explanations for these observations are. a) insufficient sensitivity of the competiti­
on ELISA. Competition titers are relatively low (1/20) in cases where epitopes of NF54 
but none of the other strains are recognized, b) ТВ-activity depends on antibody reactivity 
against as yet unknown Pfs48/45 epitope(s), c) antibody reactivity against other molecules, 
d) antibody-independent reactions 
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Studies on different isolates of Ρ falciparum show that epitopes I, lib and III are 
conserved while variations exist in expression of epitope Ha and He (Table 4). This result 
confirms earlier observations from a larger study by Foo et al [5] Appropriate isolates 
(NF54 for He and 7G8 for Ha) were used in the competition-ELISAs to determine presence 
of Ha and/or He reactivity in field sera. Competition reactivity for both epitope Ila and He 
was found in sera from the two Dutch expatriates and in 3 sera of Cameroon Foo et al 
[5] found in one isolate in which individual gametocytes expressed both forms (Ha and lie) 
using the immunofluorescence technique It implies a more complex explanation of the 
relationship between these subepitopes than allelic alternatives These findings of expres­
sing both forms has to be proven with different isolates by the PCR technique of Koeken et 
al [ И ] 
The proportion of sera from 52 gametocyte carriers with antibodies competing individu­
al Pfs48/45 mAb ranged from 13% to 33% suggesting epitope restricted immune reactivity 
The TB-bioassay is a labor-intensive and time-consuming test. As shown in this study the 
majority of ТВ-sera from Cameroon can be predicted by Pfs48/45 competition ELISA 
which may be a useful tool in further epidemiological studies on TB-immunity. 
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Longitudinal changes in antibodies and 
transmission-blocking activity of human sera 
after a Plasmodium falciparum malaria infection. 
W. ROEFFEN, K. TEELEN, M. BOLMER, W. HUNG AND R. SAUERWEIN. 
University of Nijmegen; Department of Medical Microbiology, section Parasitology 
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ABSTRACT 
A longitudinal study was carried out with blood samples from five adult Ρ .falciparum 
malaria patients. Sera were tested for their transmission-blocking capacity and antibodies 
against antigens of P.falciparum asexual and sexual parasites detected by a) immunofluo­
rescence assay (IFA) and b) competitive ELISAs against different epitopes of Pfs48/45 
and Pfs230. Transmission-blocking (ТВ) activity was present in sera from patient Ha, Sp 
and Ro for at least 17, 83 and 12 weeks respectively. A close association was found 
between increase and decrease in antibody titres to epitope III of Pfs48/45 in the competi­
tion ELISA and the ТВ-activity of the individual sera. The prevalence of antibodies 
against asexual or sexual parasites was significantly higher in the three patients with a 
malaria history, than in two patients with a first infection and no gametocytes. 
INTRODUCTION 
Plasmodium species are transmitted to the Anopheles vector by ingestion of gametocy-
taemic blood. Gametocytes of P.falciparum synthesize Pfs230 and Pfs48/45 which are ex­
pressed on the surface of macrogametes and zygotes [9,17,26]. At least five epitopes of 
Pfs48/45 or Pfs230 were identified respectively by Carter et al. [1,2], Targett et al. [23] 
and by Read et al. [16] and confirmed by Roeffen et al. [18,19]. ТВ-activity was not 
considered to be associated with particular epitopes as blocking- and non-blocking mAbs 
competed for the same binding site in competmon-ELISAs. A number of studies indicate 
that antibody responses to epitopes of Pfs48/45 and Pfs230 are part of the response 
observed after several malaria episodes [3,5,7] and that some epitopes are conserved in 
many isolates [4]. Immuno-precipitation with sera from people living in endemic areas 
precipitated radio-iodinated Pfs48/45 and Pfs230. A good correlation was found between 
ТВ-activity of the serum and antibody response against Pfs230 using the immunoprecipita-
tion assay in sera from Papua New Guinea. In addition, no such correlation was found for 
the Pfs48/45 antibody reactivity [5. On the other hand, in a study using sera from Sri 
Lanka no correlation was found between ТВ-activity and the presence of antibodies against 
Pfs230 using the same immunoprecipitation technique [15]. We have previously described 
an association between ТВ-activity of in vitro cultured gametocytes to mosquitoes in a 
bioassay and reactivity in an anti-Pfs48/45 two-site competition ELISA in several sets of 
sera [18,20]. The results show a 100% specificity and an overall relative sensitivity of 
75% for prediction of ТВ-activity using 6 anti-Pfs48/45 mAbs recognizing different 
epitopes. No correlation was found between ТВ-activity and reactivity in an anti-Pfs230 
two-site competition ELISA in sera from gametocyte carriers [19]. 
The aim of the present study was to determine the prevalence, development and 
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persistence of naturally occuring antibodies against Pfs230 and Pfs48/45 and their associa­
tion with ТВ-activity. Five patients admitted to hospital with a Ρ .falciparum infection were 
studied for a period of up to 80 weeks. Parasitological, serological and in vitro transmissi­
on data were collected to study conditions for development and persistence of asexual and 
sexual stage antibodies and their relation to ТВ-immunity. In addition, this study describes 
development, persistence and fading of ТВ-immunity after radical cure of a P.falciparum 
infection. 
MATERIALS AND METHODS 
Patients 
Blood samples were obtained from 5 patients (Ha, Sp, Ro, Ja and Gr) with clinical malaria 
at presentation at the Academical Hospital St. Radboud in Nijmegen. Patient Ha, Sp, 
Ja and Gr were all Europeans. Patient Ha and Sp were expatriates living in malaria 
endemic areas in East-Africa (Mozambique, Kenia) and West-Africa (Cameroon) for 
respectively 12 and 30 years with regular attacks of clinical malaria. Two patients (Ja 
and Gr) presented with a first malaria infection after returning from Cameroon. Patient 
Ro was borned in Irian Jaya and has lived there for 25 years thereby experiencing 
several malaria infections. Thereafter she lived in the Netherlands for 7 years. After a 
short visit to Irian Jaya she returned with a malaria infection. 
Patient Ja and Gr indicated that they visited the hospital within a week after the first 
clinical symptoms, whereas patient Ha, Sp and Ro complaints were present for two 
weeks or more. Blood samples were obtained at different time points after treatment 
(see Table 1) for a) parasitologic examination and b) serologic analysis (stored at -
20°C until use). 
Pooled serum obtained from Dutch bloodbank donors, without a history of malaria, was 
used as a negative control (N56). 
Parasitological examinations. 
P. falciparum malaria was diagnosed in Giemsa-stained thick and thin blood films. 
Asexual parasites and gametocytes were counted per 500 leukocytes and the total number 
of parasites was calculated against the number of leukocytes per μ\. A blood film was 
considered negative when no P.falciparum parasite was found per 2000 leukocytes. 
Monoclonal antibodies (mAbs) 
Anti-Pfs230 mAbs 18F25, 63F6D7 and 63F3C8 have been described previously [191. 
Anti-Pfs48/45 mAbs IA3.B8 (epitope IIa) and IIC5.B10 (epitope III) were a kind gift of 
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Dr R Carter MAbs 82D6 -AIO (epitope lie) and 84A2 A4 (epitope V) were a kind gift 
of Dr G Targett MAbs 32F3 (epitope I) and 32F1 (epitope lib) have been described 
previously [18,26] 
Parasites 
Mature gametocytes of Ρ falciparum (isolate NF54, Amsterdam airport strain, and 
7G8, Brazillian strain) were produced in an automated static culture system as described 
by Ponnudurai et al [12] Mature gametocytes were a) isolated as previously described 
[19] and stored at -70°C until used or b) allowed to undergo gametogenesis for 30 min by 
resuspension at a 10% haematocrit in Foetal Calf Serum The gametes were isolated at 
4°C as previously des-enbed [26] and used directly for suspension-IFA 
Gametocytes of isolate NF54 or 7G8 were extracted in 25 raM Tns-HCl (pH 8 0) 
supplemented with 150 mM NaCl, 0 5% Nonidet P40 (NP40), 1 mM phenylmethylsulp-
honyl fluoride and 1 μg/ml each of DNase and RNase Insoluble debris was pelleted by 
centnfugation (16,000g, 5 minutes at room temperature) and the supernatant was stored at 
-20°C until used as source of Pfs48/45 or Pfs230 in the capture ELISAs 
Transmission blocking assay 
In a previously described bioassay [13,14,26], A gambiae mosquitoes were allowed to 
feed on membrane feeders with cultured NF54 gametocytes in the presence of test or 
control sera, heat inactivated at 56UC for 30 minutes, and 12 5% fresh human serum as a 
source of complement The percentual reduction ot oocysts was calculated as described 
previously [19] The ТВ-titre is the maximum dilution of the serum still having >85% 
reduction of the oocyst number as compared to controls 
Serologic analysis 
a) Indirect immunofluorescence (IFA) 
A mix of cultured asexual and sexual stage parasites from an isolate of Ρ falciparum 
(NF54) were air-dried on multispot slides and incubated with two-fold dilutions of the test 
sera (starting with 1 20) in phosphate buffered saline (PBS) for 30 minutes The slides 
were rinsed with PBS and incubated with fluorochrome-conjugated goat-anti-human 
Immunoglobuline lg(G,M,A) for 30 minutes The slides were rinsed, washed, mounted 
with a mixture of 90% glycerol and 10% Tns-HCl (pH=9 0) under a coverslip, and 
examined under ultraviolet illumination with a Leitz microscope The end point was taken 
as the last dilution of the serum showing clear asexual and/or sexual stage parasites 
specific green fluorescence 
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b) Suspension-IFA (SIFA) 
Surface immunofluorescence was done on suspensions of live female gametes diluted 
to 108 gametes/ml in PBS containing 10 μ\ packed normal human erythrocytes. 106 game­
tes were incubated with 20 μ\ serum dilutions for 25 min. Gametes were washed twice 
with PBS and incubated for a further 20 min with 50 μ\ of 1:125 dilution in PBS with 
0.05% Evans blue of a fluorescein conjugated anti-human Ig(G,A,M). Gametes were then 
washed twice with PBS and resuspended in 50 μΙ of PBS and observed under UV illumi­
nation at a magnification of x400. The highest dilution of a serum that gave a green 
fluorescence of the membrane of live gametes was considered as the antibody titre. All 
incubations were done on ice and fluorescein conjugated mAb 32F3 was used as a control 
on round forms. 
c) Two-site competition Enzyme-Linked Immunosorbent Assays (ELISAs) 
Sera were screened for antibodies to different epitopes of Pfs48/45 and Pfs230 using 
two-site competition-ELISAs as described previously [18,19]. Briefly, unlabelled mAbs 
(10 /¿g/ml) were coated to plates and Pfs230 or Pfs48/45 was captured from an NP40 
extract of gametocytes (see above). Horseradish peroxidase (HRPO) labelled mAbs were 
used as second antibody and for competition with test sera. NP40 extracts of NF54 were 
used as a source of Pfs230 and Pfs48/45 for all competition tests except for the analysis of 
Pfs48/45 epitope Ha where the 7G8 stabilate was used. Labelled anti-Pfs230 mAbs 18F25, 
63F6D7 and 63F3C8 were used to detect antibodies in test sera that could competively 
bind to respectively epitope I, II and III whereas for Pfs48/45 labelled mAbs 32F3, 
IA3.B8, 32F1, 82D6.A10, IIC5.B10 and 84A2.A4 were used for the competition with 
antibodies that recognize respectively epitope I, IIa, IIb, lic, III and V. The optimal 
concentrations of the capture antigen and the HRPO-labelled mAbs for the competition 
ELISAs were determined in previous studies [18,19]. The negative controls did not reduce 
the OD reading of the labelled mAbs for any of the Pfs230 or Pfs48/45 epitopes. The 
competition titre was defined as the dilution of the test serum that resulted in the same OD 
value as the mean +2SD OD value for 14 non-exposed control sera. Sera with a competi-
tion titre > 1/20 are considered positive [18J. 
For the purpose of standardization in each ELISA a positive and a negative control 
were included. The optical density was read at 450 nm in a Titretek (Flow Laboratories) 
multiscan spectrophotometer. 
RESULTS 
Parasitological findings in patients. 
Two patients (Ja and Gr), with no malaria history, showed a positive thick smear for 
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asexual Ρ falciparum parasites with a parasite density of 9% and 1% respectively Game-
tocytes could not be found in the initial and weekly follow-up thick smears over the next 3 
weeks. Patients (Ha, Sp and Ro) with clinical symptoms for malaria of at least 2 weaks, 
were positive for P.falciparum, in all three patients trophozoite density was <0.01% and 
the gametocyte density 0.2%, <0.01% and <0.01% (12960, 35 and 264 gametocytes/μΐ) 
respectively. 
Two weeks before admission a blood sample of patient Sp was taken which was 
negative for malaria parasites Four days befor admission the patient treated himself with 
chloroquine. On admission, blood samples were collected and the thick smear was positive 
for P.falaparum gametocytes (35/μ1) and no trophozoites were found. No further specific 
treatment was given Patient Sp showed a recrudescence with a parasitemia of < 0 01 % 
(77 trophozoites/μΐ and 6 gametocytes/μΐ) 3 weeks after admission but one week after 
treatment with Fansidar and Quinine the patient had cleared all parasites and remained 
negative thereafter. The three gametocyte carriers cleared their gametocytes within three 
weeks after anti-malaria chemotherapy and remained negative thereafter. 
Blood samples collected at admission of patient Ha and Ro were fed a) directly and b) 
after replacement of plasma by normal human serum to mosquitoes The material ot both 
patients transmitted the infection with a high oocyst load (geometric mean oocyst number 
of 175 and 25 respectively) and 90 - 100% mosquito infection rate independent of the 
presence of own plasma or replacement by serum Comparable observations were made 
one week after the start of therapy 
Transmission-blocking activity 
Longitudinally collected serum samples of the five patients were analysed for their TB-
activity. The sera of patients Ja and Gr (first infection) did not block the transmission 
The sera of patients Ha, Sp and Ro were tested in threefold dilutions Results of the 
bioassay and ELISA are presented in Table 1 and Figure 1 Only serum of the patient Sp 
blocked the transmission on admission A maximum ТВ-titre of >81 was obtained in sera 
of patient Sp over the next 3 weeks and thereafter the titre decreased but significant 
blocking activity remained until week 83 after admission The sera of patients Ha and Ro 
developed ТВ activity in the first and second week respectively after admitted to the 
hospital which remained positive for at least three months 
Antibody reactivity against Pfs230 and Pfs48/45 
Sera of patients Ha, Sp and Ro were analysed for the presence of anti-Pfs230 and 
Pfs48/45 antibody reactivity in competmon-ELISAs Table 1 shows the results of competi 
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TABLE 1. Transmission-blocking activity (R) in the bioassay and reciprocal competition 
ELISA titres for Pfs230 (epitope I) and epitopes of Pfs48/45 of P.falciparum sexual 
stage parasites in serum samples of 3 gametocyte carriers. 
Epitope of Pfs48/45* 
Wks 
ad m 
1 
3 
10 
17 
53 
-2 
ad m 
3 
20 
35 
83 
ad m 
1 
2 
3 
4 
12 
R' 
<3 
3 
27 
9 
9 
<3 
9 
;>8i 
>81 
9 
9 
3 
<3 
<3 
3 
3 
nd 
9 
Pfs230 
<20 
<20 
<20 
<20 
<20 
<20 
80 
1280 
2560 
1280 
320 
80 
<20 
<20 
20 
80 
80 
320 
I 
160 
160 
1280 
640 
80 
20 
160 
640 
2560 
640 
80 
40 
<20 
<20 
20 
40 
80 
80 
Ha 
<20 
<20 
160 
40 
20 
<20 
80 
640 
1280 
640 
160 
80 
<20 
<20 
<20 
<20 
<20 
<20 
lib 
<20 
20 
320 
40 
40 
<20 
<20 
<20 
<20 
<20 
<20 
<20 
<20 
<20 
<20 
<20 
<20 
<20 
He 
<20 
40 
160 
40 
80 
<20 
<20 
80 
80 
80 
40 
40 
<20 
<20 
20 
40 
40 
40 
III 
<20 
20 
160 
80 
20 
<20 
160 
2560 
2560 
1280 
160 
80 
<20 
<20 
20 
80 
80 
160 
V 
20 
20 
40 
40 
40 
<20 
320 
2560 
2560 
1280 
160 
80 
<20 
<20 
<20 
20 
20 
40 
4
 = A NP40 extract of NF54 parasites was used as a source of Pfs.230 and Pfs48/45 antigen 
in all competition ELISAs except for epitope Ha of Pfs48/45 where an extract of 7G8 
parasites was used, * = reciprocal dilution of the serum with à 85% TB-activity. 
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tion on epitope I of Pfs230. Comparable results were found for epitope II and III of 
Pfs230 (data not shown). The competition-Pfs230 titre of sera from patient Sp and Ro 
increased and remained positive for at least 83 and 12 weeks respectively. Sera of patient 
Ha remained negative in all Pfs230 competition-ELISAs despite the presence of gametocy-
tes for a period of approximately 3 weeks. 
The results of the competition ELISAs with different epitopes of Pfs48/45 are also 
shown in Table 1 Patient Ha produces antibodies against all epitopes of Pfs48/45 whereas 
patient Sp and Ro do not produce competing antibodies against epitope lib and epitope Ha 
and lib respectively A positive competition-ELISA titre to any of the Pfs48/45 epitopes is 
not always associated with ТВ-activity. For example in patient Ha a titre of 1.160 against 
epitope I coincides with no blocking activity in the admission sample, whereas a titre of 
1 80 in the sample of week 17 is associated with a ТВ-titre of 1:9. There is good agree­
ment between ТВ-activity and the competition-ELISA titre against epitope III of Pfs48/45 
(Figure 1). The sera of patients Ja and Gr (first infection) were negative in all 
competition-ELISAs for both Pfs230 and Pfs48/45. 
Antibodies against asexual and sexual stage parasites 
The antibody reactivity against asexual- and sexual stage parasites of isolate NF54 
were determined by IFA and suspension-IFA (SIFA) in serum samples from patients Ja 
and Gr (first infection) and patients Ha, Sp and Ro (with a history of malaria) 
On admission patient Ja showed an asexual parasite IFA-titre of 1/1280. Patient Gr 
was negative despite a parasitemia of 1%, but showed a titre of 1/320 one week after start 
of treatment. The IFA-titre decreased over time but remained detectable for at least 8 
weeks (data not shown) Patients Ha, Sp and Ro exhibited IFA-titres against asexual 
parasites of 1/5120 which persisted for 10 weeks and then started to decline but remained 
positive for at least 83 weeks in sera of patient Sp (Figure 2) 
In the IFA on gametocytes the sera of patients Ja and Gr remained negative whereas 
the sera of patients Ha, Sp and Ro showed a maximum titre of respectively 1/320, 1/2560 
and 1/640. Antibody titres in the gametocyte IFA increased during the time that gametocy­
tes are detectable in the thick smear and decreased slowly thereafter (Figure 2) As shown 
for patient Ha and Ro, there is no correlation between a positive IFA and TB-activity 
The sera of these five patients were further analysed on reactivity with the surface of 
gametes using the SIFA The sera of patients Ja and Gr were negative whereas the sera of 
gametocyte carriers Ha, Sp and Ro showed a positive reaction with the surface of the 
gametes and the SIFA-titres are depicted in Figure 2 As shown in sera from patient Ha 
and Ro, a positive reaction could be detected in the SIFA without ТВ-activity as measured 
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Pfs48/45 competition titer TB-titer 
О 1 0 2 0 3 0 4 0 5 0 6 0 7 0 BO 
О I O 2 0 ЭО 4 0 SO 6 0 7 0 BO 
О 1 0 2 0 3 0 4 0 5 0 6 0 7 0 BO 
w e e k s 
Figure l : Relationship of competition ELISA values (X) for epitope III of Pfs48/45 
and ТВ-activity (>85%) (X) in sera from three gametocyte carriers (patient Ha, Sp or 
Ro) on admission and after treatment. 
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Figure 2: Antibody reactivity against asexual (X) and sexual (+) parasites as detected 
in the IFA and against gametes (X) using the SIFA in sera from patients Ha, Sp and 
Ro with a P.falciparum malaria history. 
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in the bioassay A remarkable observation is that the SIFA-titre reach higher values in 
comparison with the IFA-titre in sera from patient Ha and Sp. 
DISCUSSION 
This study describes presence, development and persistence of antibody reactivity 
against asexual and sexual stage parasites and of ТВ-immunity in five patients with a 
Ρ falciparum malaria infection. In two patients only asexual stage parasites were found, 
and one patient already had at admission antibodies against trophozoites; the other patient 
developed such antibodies during and after therapy. Both were negative in antibody tests 
performed with antigens of the sexual stages This absence of circulating antibodies 
against the sexual stages might indicate that these patients had been infected for the first 
time 
Antibody responses to gametocytes antigens are observed after exposure to Ρ falcipa­
rum [5,6,7,8,11,18,19,22,24J Shute and Maryon [22| studied patients with a primary 
infection and observed that 45% did not develop gametocytaemia detectable in blood 
smears, whereas Ong et al. [11] found that 12 out of 14 patients with a primary infection 
developed sexual stage antibodies as detected by IFA but observations on gametocytes in 
blood smears were not included in this study. Also Mendis et al. [10] reported about 
rapidly induced antibody reactivity against gametocytes, even with ТВ-activity, in sera 
from gametocyte carriers during primary Ρ νιναχ infections in Sri Lanka Shute and 
Maryon [22] indicated that only when parasite patency persisted for a period of three 
weeks or more the chances of the detection of a gametocytaemia detection were high 
Patients Ja and Gr indicated that they visited the hospital within a week after the start of 
their illness, and this may explain the absence ol a gametocytaemia in these patients 
The (S)IFA analyses show that in patients with a malaria history SIFA-titres are higher 
than IFA-titres for as yet unknown reasons Since a positive SIFA indicates antibody 
reactivity to the surface of activated extra-erythrocytic gametocytes or free gametes/-
zygotes it is a good candidate for correlation with ТВ-immunity. Premawansa et al. [15] 
found a strong correlation between the intensity of response to gamete surface antigens by 
SIFA and ТВ-effects of these sera from Sri Lanka. Our data show, however that a) SIFA 
titre may be high before ТВ-immunity has been developed which is clear in the first 
samples of patients Ha and Sp and b) the SIFA titre does not correlate with the TB-titre. 
In view of cross reactivity between different stages due to common molecules and cross-
reactions of antibodies stimulated by different antigens as observed by Saul et al [21] it is 
advisable lo analyse antibody reactivity and ТВ-immunity at the epitope level 
Patients Ha and Ro were admitted with a gametocytaemia, which could effectively be 
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transmitted to mosquitoes in the presence of own plasma or after replacement by normal 
serum, indicating that these patients had no ТВ-activity in their serum. ТВ-activity develo­
ped in time in these patients and persisted after disappearance of the gametocytes. It 
should be noted that peak antibody titres were observed approximately three weeks after 
admission, which may be approximately five weeks or more after the first complaints. 
Development of ТВ-immunity coincided with development of antibodies that reacted 
with epitopes on Pfs48/45 as detected in competition-ELISAs and there was a good 
agreement between ТВ-immunity and competition-ELISA titres particularly to epitope III. 
Ong et al. [11] found with epitope III the most competition reactions in comparison with 
epitope He and V in sera from patients with a primary infection or with a malaria history. 
Together these data suggest that in these patients Pfs48/45 could be a target of TB-immu-
nity. In two studies Graves et αι. [5,6] could not detect a correlation between TB-immuni-
ty and competition of antibodies for binding to epitope III of Pfs48/45 in a panel of Papua 
New Guinea sera. In a later study Graves et al. [8] found a significant association between 
ТВ-activity and recognition of epitope Ha. We have previously decribed a good correlation 
(100% specificity and 75% overall relative sensitivity) between ТВ-activity using a feeder 
assay with NF54 Ρ .falciparum parasites and reactivity in Pfs48/45 competition-ELISAs 
[20]. The data described here largely confirm this correlation except for epitope I. Sera 
collected from patients with a malaria attack >6 months ago were positive in the competi­
tion ELISA only against epitope I of Pfs48/45 and negative in the ТВ-assay (data not 
shown). It seems, that antibody reactivity over epitope I of Pfs48/45 is predominant again­
st the other epitopes and does not associate with TB-activity. 
A remarkable observation is that patient Ha did not show antibody reactivity against 
Pfs230 in competition-ELISAs including several epitopes, suggesting that in this patient 
Pfs230 may not be the target of TB-immunity. 
The gametocytaemia at admission and during therapy is not directly related to the TB-
titre or the titres of the competition-ELISAs observed later on. The gametocyte load 
before admission and particularly the exposure to gametocytes at previous infections may 
play an important role in these parameters as was also suggested in a study by Mendis et 
al. [10] with respect to P. vivax infections. 
Titres in all antibody tests against both asexual and sexual stage parasites were highest 
in patient Sp. This may be explained by recurrent parasitemias during his stay as an 
expatriate for a period of 30 years with repeated malaria infections or by the recrudescen­
ce. Taylor et al. [25] hypothesized that repeated parasitemias would result in increased 
antibody titres and/or increased antibody quality (i.e. affinity, avidity, isotype, etc). The 
higher titres may therefore be the result of a specific boosting of a previous immunologic 
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response 
A remarkable observation is the long period of ТВ-immunity in the 3 patients with a 
malaria history after radical cure, which persist until week 83 for patient Sp The long 
period of ТВ-immunity observed in these patients in the absence of the parasite is at 
variance with a common view and so encouraging with regard to feasabihty of future ТВ 
vaccine based on antigens of the sexual stages of the parasite, Pfs48/45 in particular, as an 
additional tool in malaria control 
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SUMMARY AND GENERAL DISCUSSION 
The first successful induction of transmission-blocking (ТВ) immunity was reported 
by Gwadz [12] and Carter & Chen [1] in 1976 for the avian malaria parasite Ρ gallina 
ceum Subsequently Carter et al [2] showed that the target proteins were present on the 
surface of both male and female gametes of Ρ galhnaceum 
Antibodies against Ρ falciparum gametocytes were found in sera from malaria ende­
mic regions [26] and the ability of such antibodies to block transmission was shown by 
Meuwissen et al [17] and Graves et al [8] ТВ-antibodies can apparently be induced 
during the natural course of Ρ falciparum or Ρ νιναχ malaria infections [4,6,8,9,chapter 
II] Remarkably, antibody concentrations are highest in individuals with an incidental 
exposure, whereas people with frequent exposure exhibit lower antibody responses [3,16] 
The target antigens of this immunity are considered to be membrane-bound proteins 
expressed on the surface of gametes when released from their erythrocytes in the mosquito 
midgut after ingestion of a bloodmeal Gametocytes of Ρ falciparum synthesize Pfs230 and 
Pfs48/45 and express these proteins on the surface of freshly released gametes and zygotes 
[15,22,25] Most epitopes of these sexual stage antigens that react with natural antibodies 
are conformation dependent As these proteins are potential candidates for a ТВ-vaccine, it 
is important that gametocytes boost immunity to these proteins during a natural infection 
Most individuals exposed to a Ρ falciparum infection with a gametocytaemia develop 
antibody responses to gametocyte antigens [4,7,18, chapter IV] The prevalence of natural 
antibodies to Pfs230 and Pfs48/45 is dependent of age and geographical origin of the 
studied population [21] Anti Pfs230 antibodies have been reported in 40 70% of the sera 
from individuals living in malaria endemic regions [7,24] and in up to 100% ot gametocy 
te carriers [chapter II] Natural anti-Pfs48/45 antibodies are found in 15-87% of sera from 
malaria endemic areas [11,23] Riley et al [23] found in a study in The Gambia that only 
50% of malaria-exposed individuals exhibited cellular or humoral responses to Pfs48/45 
but according to their opinion responsiveness could not be explained by MHC class II 
restriction Other explanations for unresponsiveness must be looked for 
The objectives of the studies described in this thesis were a) the development of 
serological tests to study the prevalence of antibodies against Pfs230 and/or Pfs48/45 in 
sera from naturally infected individuals and b) to study the association between the presen 
ce of these antibodies and the capacity of sera to block Ρ falciparum transmission 
At least five different epitopes of Pfs230 can be detected using a panel of mouse anti 
Pfs230 mAbs All these mAbs of the complement fixing lgG2a/IgG2b subclasses block 
transmission by lysis of released gametes, whereas none ot the IgGl mAbs (no capacity to 
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fix complement) show this activity independent of their epitope specificity |chapter III]. 
Thus, both lytic TB-mAbs and non-blocking mAbs can compete for binding to a given 
epitope [chapter II and III) Complement dependent lysis of gametes and zygotes in vitro 
by anti-Pfs230 mAbs has also been described for P.galhnaceum parasites by Quakyi et al. 
[201 and Kaushal et al. [13] 
Immunoprecipitation experiments indicated that the presence of anti-Pfs230 antibodies 
correlate with ТВ-activity in sera from an endemic area in Papua-New Guinea [8] whereas 
no correlation was found in sera from Sri Lanka [19]. ТВ-activity was observed in 40% of 
the sera from a group of gametocyte carriers from Cameroon; all these sera ìmmunopreci-
pitated Pfs230 [chapter II] and reacted in isotype specific Pfs230 ELIS As [data not shown-
] Furthermore, only 10% of these sera exhibited activity in one of the anti-Pfs230 compe-
tition-ELISAs (C230-ELISAs) A possibly explanation for different reactivities in these 
assays may be the low affinity of these natural anti-Pfs230 antibodies in comparison with 
that of competing mAbs Our serological data neither show a correlation between immun-
oprecipitation of Pfs230 and ТВ-activity nor between ТВ-activity and titers of C230-
ELISAs [chapter 11,1V and VII]. 
None of the sera from gametocyte carriers with ТВ-activity exhibited a complement 
dependent lysis of gametes as described for the anti-Pfs230 mAbs Furthermore, all these 
sera are positive in the isotype specific anti-Pfs230 ELISAs. Interestingly, IgGl and IgG3 
are prominent isotypes reacting with Pfs230 in these sera, while IgG2 and IgG4 are low 
or absent |data not shown]; notwithstanding the fact that these isotypes are the principle 
subclasses that fix complement, no lysis of gametes was observed with these sera The 
discrepancy between lytic reactivity of complement binding mouse anti-Pfs230 mAbs and 
the corresponding natural human antibodies that lack lytic activity remains to be explai­
ned 
In conclusion, the presence of anti-Pfs230 antibodies in natural sera, even of comple­
ment fixing isotypes, is not associated with ТВ-activity. These data do not support an 
important role for anti-Pfs230 antibodies in natural ТВ-activity Discrepancies with other 
studies may be related to differences in studied geographical region and methods used. 
A comparison analysis was made between the titre in a anti-Pfs48/45 competition-
ELISA (C45-ELISA) with a TB-mAb (32F3; epitope I) and ТВ-activity (bio-assay) in 
serum samples of a group of A) European expatriates with incidental exposure to malaria, 
B) Cameronian gametocyte carriers and C) randomly selected schoolchildren from malaria 
endemic areas in Cameroon Of all serum samples with TB-activity, 47% of group A, 
52% of group В and 20% of group С were positive in the C45-ELISA; the overall sensiti­
vity was 44% with a relative specificity of 94% implying a fair to good agreement [chap-
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ter V]. Serum samples that were positive in more than one epitope-specific C45-ELISA 
were all positive in the ТВ-assay Interestingly, reactivity m the epitope I specific C45-
ELISA did not correlate with ТВ-activity in a) one out of three serum samples of two 
European expatriates (different from group A) taken before occurence of TB-immuniiy 
[chapter VII] and b) in seven sera out of another group of eight European expatriates with 
no ТВ-activity who experienced their last infection six months or longer before sampling 
[data not shown] Reactivity to epitope I may therefore be associated with ТВ-activity only 
during a part of the period of the anti-Pfs48/45 antibody response 
Sera from another group of Cameraman gametocyte carriers were analysed using 
C45-ELISAS for five different epitopes of Pfs48/45 [chapter VI]. Comparison of TB-
activity and competition reactivity for five epitopes of Pfs48/45 shows a relative specifici­
ty of 100% and a relative sensitivity of 25%, 39%, 61%, 54% and 57% for respectively 
epitope I, lib. He, III and V with an overall sentitivity of 75% Ong et al [18] found in 
sera from malaria patients, with either a primary infection or with a malaria history a 
higher frequency of competition reactivity for epitope III than for epitope He or V but 
correlation with ТВ-activity was not determined in these sera. Graves et al [8] found no 
correlation between serologic reactivity to Pfs48/45 and ТВ-activity in a panel of sera 
from Papua New Guinea using immunoprecipitation of Pfs48/45 and competition of 
antibodies with mAb epitope III of Pfs48/45 [7J Discrepancies between this and our 
studies may be related to differences in immune reactivity in populations from geographi­
cally different areas 
Studies on different isolates of Ρ .falciparum showed that antibody reactivity to 
epitopes I, lib and III were comparable while variations existed in reactivity to epitope Ha 
and He [chapter VI]. This result is in line with observations by Foo et al [5] who showed 
that epitope 1, lib, III and IV are conserved and epitope Ha and He are allelic forms of 
Pfs48/45. Competition reactivity for both epitope Ha and He was found in sera from 
Dutch expatriates and in 3 out of 11 sera from Cameraman gametocyte carriers [chapter 
VI]. Drakeley et al. Ipersonal communication] found mixed infections of lla/IIc in the 
Gambia, Cameroon, Tanzania and Thailand whereas only IIa was detected in Brazil using 
the polymerase chain reaction (PCR) technique [14]. Our data confirm antibody reactivity 
against both epitope Ha and He parasatised infections in some sera from Cameroon [chap­
ter VI] Preliminary data suggest that ТВ-activity is probably not dependent on reactivity 
against the Ila or Ile allei of Pfs48/45 |chapter VII] 
In a longitudinal study (up to 80 weeks) in P.falciparum infected expatriates from 
malaria endemic areas, development of ТВ-immunity correlated with C45-ELISA titers 
particularly to epitope III. The titres in these sera (up to 1/2560) were significantly higher 
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than those in gametocyte carriers from Cameroon (up to 1/80) [chapter VI and VII] This 
corresponds with reactivity observed respectively after incidental or continuous exposure 
as described by Carter et al [3] and Lulat |16] Graves et al [10] found four distinct 
patterns in time-course responses to four epitopes of Pfs48/45 using the C45-ELISA of 
endemic sera, marking the complexity of the antibody response to Pfs48/45 These and 
our findings indicate that studies on a relation between serologic reactivity and TB-activity 
should be carried out at the epitope level 
Interestingly, not only titres but also the relative specificity and sentivity of epitope I 
and epitope III specific C45-ELISAs differ between the groups European expatriates and 
gametocyte carriers from Cameroon The relative sensitivities for epitope I in the C45-
ELISA were 71% (n=53) and 35% (n=174) with relative specificities of 71% and 95% 
and for epitope III, relative sensitivities were 94% (n=26) and 54% (n=52) with corre­
sponding relative specificities of 90% and 100% respectively in the expatriates and game­
tocyte carriers. These data show that overall the C45-ELISA for epitope III is a better 
marker than that for epitope I for the comparison with ТВ-activity in serum samples 
Another interesting observation in our study with Europian expatriates was the period 
of persistence of ТВ-immunity ranging from 50 to 80 weeks after the last exposure to 
gametocytes This long period of ТВ-immunity in the absence of the parasite is encoura­
ging for the development of a TB-vaccme based on antibody reactivity against gametocyte 
antigens and against Pfs48/45 in particular. No data are available on persistence of esta­
blished ТВ-immunity against P.falaparum in endemic areas Mendis et al [6] found that 
loss of ТВ-activity can occur in the absence of re-exposure to P.vivax malaria in a period 
of four months 
There is no consistency in the relationship between antibody titers against antigens of 
the sexual stages and ТВ-activity in different studies. This may be due to differences in 
endemicity of malaria in the groups studied. Studies on ТВ-activity and reactivity in C45-
ELISAs involving all available epitopes in populations which differ in age, geographic 
origin and exposure to different transmission intensities may clarify this point. In addition, 
studies on strain specificity of ТВ-immunity and corresponding C45-ELISAs need to be 
expanded Such studies may reveal whether or not ТВ-activity under field conditions is 
strain, molecule and/or epitope specific These data are needed to define a role for Pfs48/-
45 in the epidemiology of malaria transmission Serological tests as described in this 
thesis, may contribute to a better understanding of the epidemiology of malaria transmissi­
on and may indirectly help to find new ways for control of malaria. 
The individual differences and the duration of individual immune responses to the 
sexual stage antigens in relation to exposure, are of great importance for the ultimate 
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SAMENVATTING 
In de tropen en subtropen is malaria een van de meest voorkomende ziekten. Jaarlijks 
maken wereldwijd ongeveer 300-500 miljoen mensen de infectie door Als gevolg daarvan 
sterven per jaar ca. 2 miljoen mensen, voornamelijk jonge kinderen en dat aantal is weer 
aan het toenemen, onder andere omdat geneesmiddelen hun werkzaamheid verliezen 
Malaria wordt veroorzaakt door een eencellige parasiet behorende tot de protozoa van het 
genus Plasmodium Van de tientallen Plasmodium soorten komen er vier bij de mens 
voor. Levensbedrijgend is Plasmodium falciparum. 
In het menselijk lichaam bevinden de parasieten zich gedurende het grootste deel van 
de tijd in de rode bloedcellen waarin een ongeslachtelijke voortplanting plaats vindt. In 
enkele parasieten wordt via een nog onbekend mechanisme de ontwikkeling van geslachte-
lijke stadia geïnduceerd. Deze gametocyten rijpen verder uit en blijven in de rode bloedcel 
tot een vrouwelijke mug (van het genus Anopheles) een bloedmaal neemt. In de maag van 
de mug komen de gameten uit de gametocyten vrij en heeft een geslachtelijke voortplan-
ting plaats. Hieruit ontstaan weer nieuwe vormen van de parasiet, die na circa tien dagen 
in de speekselklieren van de mug nestelen. BIJ een steek van deze geïnfecteerde mug 
komen de parasieten, sporozoieten genaamd, in de bloedbaan van de mens en zorgen voor 
een infectie. 
Een van de mogelijkheden ter bestrijding van malaria is de ontwikkeling van een 
vaccin. Minstens drie vaccin typen zouden hiervoor in aanmerking kunnen komen; a) een 
sporozoieten vaccin kan de gastheer beschermen tegen het binnendringen van de parasiet 
in de levercellen en daarmee de verdere ontwikkeling van de parasiet blokkeren, b) een 
merozoieten vaccin kan alleen de asexuele cyclus onderbreken en zo het ontstaan van de 
ziekte-verschijnselen voorkomen en c) een vaccin tegen sexuele stadia kan de verdere 
ontwikkeling van de parasiet in de mug blokkeren en daardoor de transmissie van de 
parasiet van de mug op de mens voorkomen 
Op de afdeling medische microbiologie, sectie parasitologic van het academisch 
ziekenhuis in Nijmegen wordt gewerkt aan de ontwikkeling van een transmissie-blokke-
rend (TB) vaccin Het startpunt in dit promotie onderzoek betrof de observatie dat bij 
mensen, die in malaria gebieden leven, antistoffen voorkomen die met de sexuele stadia 
van de parasiet reageren en dat sommige daarvan de ontwikkeling van de parasiet in de 
malaria mug kunnen blokkeren Er zijn monoclonale antistoffen (mAbs) ontwikkeld, die 
zich binden aan de oppervlakte eiwitten van de sexuele stadia van de parasiet in de mug 
en die daarbij de ontwikkeling van de parasiet blokkeren 
Met behulp van transmissie blokkerende antistoffen zijn oppervlakte eiwitten van de 
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parasiet geïdentificeerd. Het bleek dat oppervlakte eiwitten die op de sexuele stadia 
herkend worden, verdeeld zijn over twee ontwikkelings fasen De eiwitten van de eerste 
vroege fase (Pfs230 en Pfs48/45) komen direct na activering van de gametocyten voor op 
het oppervlak van de gameten/zygoten en antilichamen hiertegen voorkomen waarschijnlijk 
de bevruchting van de vrouwelijke gameet. In de tweede fase, vanaf ongeveer drie uur na 
de aktivatie van de gametocyten en vorming van Zygoten, komt eiwit Pfs25 aan het 
oppervlakte van de gameten/zygoten, wanneer Pfs230 en Pfs48/45 grotendeels zijn afge-
stoten Bij de mens zijn alleen antistoffen gevonden tegen de eiwitten van eerste vroege 
fase en niet van tweede fase. 
In de afgelopen 10 jaar is immunologisch onderzoek gedaan naar de antistoffen die 
zich binden aan deze oppervlakte-eiwitten van de parasiet. Het in dit proefschrift beschre-
ven onderzoek gaat over antistoffen die gericht zijn tegen de vroege fase 1 eiwitten, 
Pfs230 en Pfs48/45. 
In een laboratonumtest (ТВ-test) voor de bepaling van transmissie-blokkerende 
antistoffen worden in vitro gekweekte gametocyten, in aanwezigheid van antistoffen 
gevoed aan vrouwelijke muggen. Zeven dagen later wordt het aantal oocysten in de 
muggemaag microscopisch geteld en het blokkerend vermogen van het te testen serum 
bepaald ten opzichte van een controle serum. Deze ТВ-test is een tijdrovende, ingewikkel­
de en dure test die veel infrastrukturele voorzieningen vergt (bv. parasieten- en muggen-
kweek) en waarmee een beperkt aantal sera kan worden getest. Daarom wordt gezocht 
naar een makkelijk te hanteren test die de aanwezigheid van transmissie-blokkerende 
antistoffen kan voorspellen 
De doelstellingen van de studies die in dit proefschrift zijn beschreven zijn als volgf 
1) de ontwikkeling van serologische testen, die de aanwezigheid van anti-Pfs230- en 
anti-Pfs48/45 antistoffen in sera van malaria patiënten aantonen, 
2) te bepalen in hoeverre deze antistoffen correleren met de capaciteit van het serum 
om de transmissie te blokkeren. 
De ontwikkeling en activiteit van anti-Pfs230 mAbs wordt in hoofdstuk 2 beschreven 
Het blijkt dat mAbs gericht tegen Pfs230 van het isotype IgG2a of IgG2b, in staat zijn om 
complement te binden en de parasiet te vernietigen, zo wordt de transmissie geblokkeerd 
MAbs tegen Pfs230 van het isotype IgGl kunnen dit niet Met deze mAbs zijn ELISA's 
ontwikkeld die een indruk geven van het epitopencomplex van Pfs230. Er blijken mini-
maal 5 epitopen te zijn, waarmee zowel blokkerende- als niet blokkerende mAbs in 
competitie met elkaar reageren. In hoofdstuk 3 wordt aangetoond dat in aanwezigheid van 
complement een met-blokkerende mAb blokkerend wordt als het isotype "switcht" van 
IgGl naar IgG2b of IgG2a Hieruit kunnen we concluderen dat complement bindende 
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mAbs gericht tegen verschillende epitopen van Pfs230 de transmissie kunnen blokkeren 
Anti-Pfs230 antistoffen komen voor in 40 70% van de sera van mensen die in ende­
mische malaria gebieden wonen en in alle mensen die uit deze gebieden met Ρ falciparum 
gametocyten in hun bloed terugkeren (hoofdstuk 2) Met de ontwikkelde Pfs230 competitie 
ELlSA's is de reactiviteit van antistoffen in humane sera bepaald Er kon geen associatie 
gevonden worden tussen de reactiviteit in de competitie-ELISA's en het blokkerend effect 
van het serum in de ТВ-test In een inleidend experiment is in veldsera het isotype van 
anti-Pfs230 antistoffen bepaald Hieruit bleek dat complement fixerende antistoffen aan 
Pfs230 binden, maar een transmissie blokkerende activiteit in dergelijke sera was niet 
complement afhankelijk Mogelijk is de affiniteit van natuurlijke anti Pfs230 antistoffen 
laag in vergelijking met die van de mAbs Dit zou erop wijzen dat de antistoffen tegen 
Pfs230 - tenminste in bepaalde groepen malaria patiënten - waarschijnlijk niet steeds tot 
blokkade van de transmissie leiden 
Anti-Pfs48/45 antistoffen komen voor in 15-87% van de sera van mensen die in 
malaria endemische gebieden wonen In het eerste onderzoek werd het transmissie blokke-
rend vermogen van een serum vergeleken met de activiteit in competitie ELISA's (hoofd-
stuk 4) In vervolg-studies wordt een vergelijkende analyse gebruikt om de overeenkomst 
tussen de activiteit in competitie-ELISA's en de TB test te bepalen in sera van a) reizigers 
uit Europa, b) gametocytendragers en c) schoolkinderen uit een endemisch malaria gebied 
in Kameroen De gecombineerde resultaten van al deze bepalingen laat een goede overeen-
komst zien tussen de resultaten verkregen met de competitie-ELISA en de TB test Met 
deze competitietesten kan 44% van de transmissie blokkerende sera worden opgespoord, 
als de reaktiviteit tegen één epitoop bekeken wordt en 50% indien twee epitopen in de 
analyse worden betrokken (hoofdstuk 4 en 5) In vervolg onderzoek worden zes verschil-
lende anti-Pfs48/45 mAbs gebruikt voor de vergelijking van de activiteit van het serum in 
de ГВ-test en de competitie-ELISA (hoofdstuk 6) Met deze competitie testen kan 75% 
van de blokkerende sera uit Kameroen worden geïdentificeerd Ook wordt in dit hoofdstuk 
aannemelijk gemaakt dat als het eiwit afkomstig is van isolaten van malaria parasieten uit 
verschillende delen van de wereld dit nauwelijks invloed heeft op de resultaten van de 
daarmee uitgevoerde competitie-ELISA's 
In een longitudinale studie met sera van mensen die meer dan 10 jaar in de tropen 
hebben geleefd en naar Nederland komen met een malaria infectie, blijkt dat de ontwikke-
ling van ТВ-activiteit overeenkomt met de ontwikkeling van antistoffen, die een epitoop-
specifieke competitie vertonen met Pts48/45 en in het bijzonder met epitoop 3 (hoofdstuk 
7) Uit deze studies blijkt dat de Pfs48/45 competitie-ELISA's al enige voorspellende 
waarde hebben ten opzichte van de transmissie blokkade activiteit van het geteste serum 
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Een opmerkelijke waarneming in dit longitudinale onderzoek was dat na blootstelling 
aan gametocyten de ТВ-immuniteit in een patient meer dan 80 weken aanhield Voor een 
vaccin op basis van dit eiwit is het belangrijk te weten hoelang deze humorale immuniteit 
na vaccinatie aanwezig blijft 
De in dit proefschrift beschreven serologische bepalingen die gecorreleerd zijn aan 
ТВ-activiteit kunnen mogelijk een bijdrage leveren aan een analyse van de epidemiologie 
van de transmissie van malaria en zo indirect aan de controle op verspreiding van de 
ziekte 
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ABBREVIATIONS 
C45-ELISA 
C230-ELISA 
ELISA 
FCS 
FITC 
FPLC 
HRPO 
IFA 
ig 
kDa 
mAb 
NP40 
OD 
PBS 
PCR 
Pfs 
PLL 
PMSF 
PVDF 
SDS-PAGE 
SIFA 
ТВ 
TX-114 
anti-Pfs48/45 competition-ELISA 
anti-Pfs230 competition-ELISA 
Enzym-Linked Immunosorbent Assays 
fetal calf serum 
fluorescein isothiocyanate 
Fast Protein Liquid Chromatography 
horseradish peroxidase 
immunofluorescence microscopy with dried parasites as the antigen 
immunoglobulin 
kiloDalton 
monoclonal antibody 
Nonidet P-40 
optical density 
phosphate buffered saline 
polymerase chain reaction 
Plasmodium falciparum surface protein 
poly-L-lysine 
phenyl-methyl-sulphonyl-fluoride 
polyvinyldifluoride 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
suspension IFA with live parasites as the antigen 
transmission-blocking 
Triton X-114 
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De schrijver van dit proefschrift werd geboren op 11 Oktober 1950 te Maasniel In 1971 
behaalde hij het diploma HBO-a aan de Analistenschool te Venlo Na 4 jaar te hebben gewerkt bij 
Diosynth te Oss begon hij in 1976 met zijn werkzaamheden in het Academisch Ziekenhuis 'St 
Radboud' te Nijmegen De eerste 5 jaar was hij werkzaam bij Dr J H M van Tongeren op het 
laboratorium van Maag- Darm en Leverziekten Sinds 1981 is hij betrokken bij het biochemisch 
en immunologisch onderzoek op het gebied van de transmissie van malaria en de ontwikkeling van 
een transmissie blokkerend vaccin op het laboratorium van de Medische Microbiologie, sectie 
Parasitologic Na het behalen van zijn HLO diploma Biologie aan de Hoge school van Amsterdam 
in 1992 begon hij met het wetenschappelijk onderzoek dat beschreven staat in dit proefschrift, 
aanvankelijk onder leiding van Prof Dr J H E Th Meuwissen en na diens emeritaat onder leiding 
van Dr R W Sauerwein en Dr W M С Eling 
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WOORDEN VAN DANK 
De schrijver van een proefschrift zou men kunnen vergelijken met een waterpoloer, 
die weliswaar veel individueel werk moet verzetten, maar slechts succesvol kan zijn door 
met de andere teamleden samen te werken Bij deze wil ik dan ook allen die aan het tot 
stand komen van dit proefschrift hebben meegewerkt van harte bedanken 
Zoals elk team een trainer en een coach kent, bedank ik mijn "trainers en coaches" 
bij deze Als eerste wil ik mijn promotor Joep Meuwissen noemen voor de kans die hij 
mij gaf een begin te maken met het wetenschappelijk onderzoek Na zijn emeritaat werd 
de begeleiding overgenomen door mijn copromotoren Wijnand Eling en Robert Sauerwein 
Robert Sauerwein stelde mij in staat veel meer facetten van het malaria onderzoek te leren 
kennen met Wijnand Eling en Pieter Beckers heb ik vele uren van wetenschappelijke 
discussies doorgebracht Allen hebben mij intensief begeleid bij de vele werkzaamheden 
en mijn immunologisch blikveld daarmee sterk verbreed 
Elk team bestaat uit een aantal spelers die op hun manier een eigen bijdrage leveren 
om tot scoren te komen Karma Teelen die vanaf het begin lot het gereedkomen van dit 
proefschrift actief betrokken was bij vrijwel alle experimenten, bedank ik voor haar 
inspiratie, accuratesse, doorzettmgs-vermogen en vriendschap Verder bedank ik Marianne 
Sieben en Truus Derks voor de bereiding van muis en rat monoclonalen, Marga Bolmer, 
Arianne Huisman, Geert-Jan van Gemert, Jo Hooghof en Jolanda Remmers voor de kweek 
van vele parasieten en de transmissie blokkade experimenten, Theo van de Ing, Geert 
Poelen en Jan Koedam van het Centraal Dieren laboratorium voor hulp bij de dierproeven 
Tevens bedank ik alle AIO en AIO-achtigen, met wie ik mijn kamer gedeeld heb, voor 
hun opbouwende en bemoedigende kritiek waarbij ik de namen van Annette Beetsma, 
Roos Perenboom, Rob Hermsen en Ton Lensen niet onvermeld wil laten 
Buiten de teamleden zijn er nog diverse mensen op de achtergrond die er indirect 
voor zorgen dat het team niets te kort komt De mensen van het lab die indirect hun 
bijdrage hebben geleverd zoals Jan Peter Verhave, Theo Arens en Tita Oetinger dank ik 
hierbij, Bert Mulder en de medewerkers van het OCEAC/ORSTOM voor het verzamelen 
van de Kameroenese sera en voor de begeleiding tijdens mijn eerste tropenervanng 
Als een speler al meerdere jaren voor een team speelt kent hij ook oud-teamleden 
Alle (ex)-medewerkers van de sectie Parasitologic dank ik voor hun getoonde bereidwillig-
heid tot samenwerking In het bijzonder wil ik hier noemen Felix Geeraedts die in het 
kader van zijn hoofdvak aan dit onderzoek heeft bijgedragen 
Het is onmogelijk om alle mensen die hebben bijgedragen aan dit onderzoek afzon-
derlijk te bedanken Ik heb vooral de laatste jaren geleerd dat goed onderzoek alleen 
mogelijk is binnen een kritische afdeling waar een goede sfeer heerst 
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De publikatie van dit proefschrift kwam mede tot stand dankzij de 
financiële steun van; 
Roche Nederland B.V. 
Nederlandse Vereniging van bioMedisch 
Laboratoriummedewerkers (NVML) 
Bio-Rad Laboratories B.V. 
Stellingen 
behorende bij het proefschrift van Will Roeffen 
Plasmodium falciparum: Relevance of 
human antibodies for blocking transmission 
of the parasite from man to mosquito. 
Nijmegen, 12 november 1996. 
De goede correlatie tussen de activiteit in de anti-Pfs48/45 
specifieke competitie ELISA's en de transmissie-blokkade 
bioassay maakt de serologische testen geschikt voor onderzoek 
naar de epidemiologische betekenis van transmissie-blokkerende 
immuniteit, (dit proefschrift) 
Gametocytaemie bij een patiënt met een Ρ .falciparum infectie is 
niet maatgevend voor de transmissie-blokkerende activiteit in het 
serum, (dit proefschrift) 
Het aantal voorafgaande P.falciparum infecties waarbij 
gametocyten tot ontwikkeling zijn gekomen bepalen de 
transmissie-blokkerende activiteit van het serum en de specifieke 
serologische reactiviteit, (dit proefschrift) 
De complement afhankelijke anti-Pfs230 antilichaam gemedi-
ëerde transmissie-blokkade die met muis monoclonalen 
antistoffen wordt waargenomen is vooralsnog niet bij de mens 
aantoonbaar, (dit proefschrift) 
Hoewel een transmissie-blokkade vaccin geen individuele 
bescherming biedt tegen malaria komt het effect van zo'η 
vaccinatie overeen met de vaccinatie van jongetjes met het 
Rubella-vaccin die bijdraagt aan de opbouw van de herd-
immunity. 
Worminfecties kunnen de immunologische responsiviteit 
polariseren en zelfs verlammen. Het zou daarom verstandig zijn 
om in "het veld" de te vaccineren personen (malaria-vaccin) 
eerst te behandelen met anthelmintica. (Clin Exp Immunol 
(1996)103:239-243, Ind J Med Res (1996)103:46-54. 
Het is de vraag of bij de ontwikkeling van een vaccin het gaat 
om de keuze van het juiste epitoop of om de toevoeging van het 
juiste adjuvants. 
Om de efficiëntie van natuurwetenschappelijk onderzoek te 
vergroten moet de rapportage van negatief uitgevallen 
onderzoeksresultaten, die voor de voortgang van het onderzoek 
belangrijk zijn, worden bevorderd. 
Door de commotie die ontstaan is rond de met BSE besmette 
Britse koeien is men dodelijk benauwd geworden voor de ziekte 
van Creutzfeldt-Jacob. In analogie met het gevoerde beleid zou 
nu ook de verkoop van GSM-telefoons verboden moeten worden 
in verband met het risico van de ontwikkeling van hersen-
tumoren. 
De tijdwinst die verkregen werd door de introductie van 
computer-programma's zoals tekstverwerkers, statistische 
paketten, spreadsheets, databases etc, wordt onderschat door de 
tijd die besteed moet worden om de (on)mogelijkheden van deze 
programma's te leren gebruiken. 
De hedendaagse beschikbaarheid van communicatiemiddelen 
zoals Fax, Email, Internet, etc, vergroot niet alleen het aantal 
contacten, maar ook het aantal misverstanden. 
Een goede biomedische onderzoeker is een goede analist. 


